Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Hepatology
    September 2021
  1. HUANG R, Liu J, Wang J, Li J, et al
    Letter to the Editor: Is hepatitis B virus genotype strongly associated with hepatocellular carcinoma risk in patients with chronic hepatitis B?
    Hepatology. 2021 Sep 14. doi: 10.1002/hep.32155.
    >> Share

  2. DUAN J, Wang Z, Duan R, Yang C, et al
    Therapeutic Targeting of Hepatic ACSL4 Ameliorates Non-alcoholic Steatohepatitis in Mice.
    Hepatology. 2021 Sep 12. doi: 10.1002/hep.32148.
    >> Share

  3. CARAPETO F, Bozorgui B, Shroff RT, Chagani S, et al
    The Immunogenomic Landscape of Resected Intrahepatic Cholangiocarcinoma.
    Hepatology. 2021 Sep 12. doi: 10.1002/hep.32150.
    >> Share

  4. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows.
    Hepatology. 2021 Sep 7. doi: 10.1002/hep.32097.
    >> Share

  5. COLL M, Arino S, Martinez-Sanchez C, Garcia-Pras E, et al
    Ductular Reaction Promotes Intrahepatic Angiogenesis Via Slit2-Robo1 Signaling.
    Hepatology. 2021 Sep 7. doi: 10.1002/hep.32140.
    >> Share

  6. ZHANG X, Yang H, Zeng S, Tian S, et al
    Melanoma-Differentiation-Associated gene 5 protects against nonalcoholic steatohepatitis in mice.
    Hepatology. 2021 Sep 5. doi: 10.1002/hep.32139.
    >> Share

  7. AN J, Kim D, Oh B, Oh YJ, et al
    Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas.
    Hepatology. 2021 Sep 3. doi: 10.1002/hep.32135.
    >> Share

  8. GORES GJ, Malhi H
    Presenting the New Incoming Editorial Team for HEPATOLOGY: Team Members and Perspectives.
    Hepatology. 2021 Sep 2. doi: 10.1002/hep.32137.
    >> Share

  9. KHAN IW, Ali MA, Lau DTY, Hang TP, et al
    Hepatology Highlights.
    Hepatology. 2021;74:1137-1140.
    >> Share

    August 2021
  10. INNES H, Crooks CJ, Aspinall E, Card TR, et al
    Characterising the risk interplay between alcohol intake and body mass index on cirrhosis morbidity.
    Hepatology. 2021 Aug 28. doi: 10.1002/hep.32123.
    >> Share

  11. PLUMMER MD, Regenstein F
    Light chain deposition disease: an unusual cause of portal hypertension.
    Hepatology. 2021 Aug 27. doi: 10.1002/hep.32118.
    >> Share

  12. FU J, Hu F, Ma T, Zhao WJ, et al
    A conventional immune regulator MAVS blocks hepatic steatosis via maintaining mitochondrial homeostasis.
    Hepatology. 2021 Aug 26. doi: 10.1002/hep.32126.
    >> Share

  13. IMAI N, Nicholls HT, Alves-Bezerra M, Li Y, et al
    Upregulation of Thioesterase Superfamily Member 2 in Skeletal Muscle Promotes Hepatic Steatosis and Insulin Resistance.
    Hepatology. 2021 Aug 25. doi: 10.1002/hep.32122.
    >> Share

  14. FAN S, Gao Y, Qu A, Jiang Y, et al
    YAP-TEAD mediates peroxisome proliferator-activated receptor alpha-induced hepatomegaly and liver regeneration in mice.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32105.
    >> Share

  15. FUCHS CD, Radun R, Dixon ED, Mlitz V, et al
    Hepatocyte-specific deletion of adipose triglyceride lipase (ATGL/PNPLA2) ameliorates dietary induced steatohepatitis in mice.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32112.
    >> Share

  16. EL KASMI KC, Ghosh S, Anderson AL, Devereaux MW, et al
    Pharmacologic Activation of Hepatic Farnesoid X Receptor Prevents Parenteral Nutrition Associated Cholestasis in Mice.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32101.
    >> Share

  17. LIN Y, Cai Q, Chen Y, Shi T, et al
    CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma via 5-lipoxygenase.
    Hepatology. 2021 Aug 13. doi: 10.1002/hep.32099.
    >> Share

  18. ALLAIRE M, Garcia-Pagan JC, Walter A, Bureau C, et al
    Salvage TIPS in cirrhotic patients with variceal bleeding: MELD, lactates and << a la carte >> decision.
    Hepatology. 2021 Aug 5. doi: 10.1002/hep.32091.
    >> Share

  19. BOSCH J, Chung C, Carrasco-Zevallos OM, Harrison SA, et al
    A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis.
    Hepatology. 2021 Aug 1. doi: 10.1002/hep.32087.
    >> Share

  20. WAHID N, Jesudian A, Buckholz A, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2021;74:539-542.
    >> Share

  21. FIX OK, Blumberg EA, Chang KM, Chu J, et al
    American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
    Hepatology. 2021;74:1049-1064.
    >> Share

  22. SAVIANO A, Wrensch F, Ghany MG, Baumert TF, et al
    Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
    Hepatology. 2021;74:1088-1100.
    >> Share

    July 2021
  23. WIN S, Min RWM, Zhang J, Kanel G, et al
    Hepatic mitochondrial SAB deletion or knockdown alleviates diet induced metabolic syndrome, steatohepatitis and hepatic fibrosis.
    Hepatology. 2021 Jul 31. doi: 10.1002/hep.32083.
    >> Share

  24. ZHANG Z, Ji Z, He J, Lu Y, et al
    GNAI2 exacerbates non-alcoholic steatohepatitis progression via regulating PRDX1-related inflammation and lipophagy.
    Hepatology. 2021 Jul 29. doi: 10.1002/hep.32078.
    >> Share

  25. SUDA T, Yoshikawa S, Kanefuji T, Abe S, et al
    Suppression of Noncoding RNAs as Shared Early Genetic Events in Multistep Hepatocarcinogenesis.
    Hepatology. 2021 Jul 29. doi: 10.1002/hep.32077.
    >> Share

  26. MA L, Xu A, Kang L, Cong R, et al
    LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance via SP1-induced p62 Transcription in Hepatocellular Carcinoma.
    Hepatology. 2021 Jul 29. doi: 10.1002/hep.32079.
    >> Share

  27. LIU G, Wang N, Zhang C, Li M, et al
    ALDOB depletion promotes hepatocellular carcinogenesis through activating insulin receptor signaling and lipogenesis.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32064.
    >> Share

  28. MCMAHON BJ, Nolen S, Snowball M, Homan C, et al
    Hepatitis B Virus (HBV) Genotype: A Significant Risk Factor in Determining which Patients with Chronic HBV Infection should Undergo Surveillance for Hepatocellular Carcinoma: The Hepatitis B Alaska (HEP-B-AK) Study.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32065.
    >> Share

  29. HU M, Zhang D, Xu H, Zhang Y, et al
    Salidroside activates the AMP-activated protein kinase pathway to suppress non-alcoholic steatohepatitis.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32066.
    >> Share

  30. HE Q, Liu M, Huang W, Chen X, et al
    IL-1beta-induced Elevation of SLC7A11 Promotes Hepatocellular Carcinoma Metastasis through Upregulating PD-L1 and CSF1.
    Hepatology. 2021 Jul 20. doi: 10.1002/hep.32062.
    >> Share

  31. YANG Q, Chen X, Zhang Y, Hu S, et al
    The E3 ubiquitin ligase RNF5 ameliorates nonalcoholic steatohepatitis via ubiquitin-mediated degradation of HRD1.
    Hepatology. 2021 Jul 17. doi: 10.1002/hep.32061.
    >> Share

  32. PIANO S, Cardenas A
    Metabolomics to predict acute kidney injury in cirrhosis.
    Hepatology. 2021 Jul 16. doi: 10.1002/hep.32060.
    >> Share

  33. MILLER BM, Oderberg IM, Goessling W
    The Hepatic Nervous System in Development, Regeneration, and Disease.
    Hepatology. 2021 Jul 13. doi: 10.1002/hep.32055.
    >> Share

  34. ZHENG J, Daniel CR, Hatia RI, Stuff J, et al
    Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A US-Based Study.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32046.
    >> Share

  35. LAI JC, Tandon P, Bernal W, Tapper EB, et al
    Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32049.
    >> Share

  36. KIM OK, Nam DE, Hahn YS
    The Panx1/P2X4 pathway controls the secretion of miRNA-containing exosomes by HCV-infected hepatocytes.
    Hepatology. 2021 Jul 4. doi: 10.1002/hep.32042.
    >> Share

  37. CAPORALI C, Turco L, Prampolini F, Quaretti P, et al
    Proximal splenic artery embolization to treat refractory ascites in a cirrhotic patient.
    Hepatology. 2021 Jul 4. doi: 10.1002/hep.32037.
    >> Share

  38. BUCKHOLZ A, Lucero C, Yang LM, Lau DTY, et al
    Hepatology Highlights.
    Hepatology. 2021;74:1-4.
    >> Share

    June 2021
  39. FLEMMING JA, Djerboua M, Groome PA, Booth CM, et al
    NAFLD and alcohol-related liver disease will be responsible for almost all new diagnoses of cirrhosis in Canada by 2040.
    Hepatology. 2021 Jun 26. doi: 10.1002/hep.32032.
    >> Share

  40. GARATE-RASCON M, Recalde M, Jimenez M, Elizalde M, et al
    SLU7 prevents oxidative stress-mediated HNF4alpha degradation preserving hepatic differentiation and protecting from liver damage.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32029.
    >> Share

  41. HIRAO H, Ito T, Kadono K, Kojima H, et al
    Donor Hepatic Occult Collagen Deposition Predisposes to Peri-transplant Stress and Impacts Human Liver Transplantation.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32030.
    >> Share

  42. KRIEGERMEIER A, Hyon A, Sommars M, Hubchak S, et al
    Hepatic X-box binding protein 1 and unfolded protein response is impaired in weanling mice with resultant hepatic injury.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32031.
    >> Share

  43. CHOLANKERIL G, Kanwal F
    Nonalcoholic fatty liver disease and Hepatocellular Carcinoma: Time to Bridge the Gap.
    Hepatology. 2021 Jun 23. doi: 10.1002/hep.32025.
    >> Share

  44. TORRENS L, Montironi C, Puigvehi M, Mesropian A, et al
    Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma.
    Hepatology. 2021 Jun 22. doi: 10.1002/hep.32023.
    >> Share

  45. LIU H, Lee SS
    Diagnostic criteria of cirrhotic cardiomyopathy: out with the old, in with the new?
    Hepatology. 2021 Jun 21. doi: 10.1002/hep.32021.
    >> Share

  46. JEPSEN P, Tapper EB, Deleuran T, Kazankov K, et al
    Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nationwide cohort study.
    Hepatology. 2021 Jun 16. doi: 10.1002/hep.32019.
    >> Share

  47. SHI YF, Xie WZ
    Letter to the Editor: Risk Stratification in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
    Hepatology. 2021 Jun 15. doi: 10.1002/hep.32013.
    >> Share

  48. MAZUMDER NR, Simpson D, Atiemo K, Jackson K, et al
    Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study.
    Hepatology. 2021 Jun 15. doi: 10.1002/hep.31742.
    >> Share

  49. LEE YT, Wang JJ, Luu M, Noureddin M, et al
    Comparison of Clinical Features and Outcomes between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Hepatology. 2021 Jun 11. doi: 10.1002/hep.32007.
    >> Share

  50. JINDAL A, Sharma S
    Biomarkers for predicting renal outcomes in decompensated cirrhosis - Need a closer look!
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.32005.
    >> Share

  51. SOLIPURAM V, Baretti M, Kim AY, Chen LX, et al
    Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31998.
    >> Share

  52. SHAH V, Iwakiri Y, Boyer JL
    Obituary for Roberto J. Groszmann - the Father of Portal Hypertension.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31996.
    >> Share

  53. KOZUMI K, Kodama T, Murai H, Sakane S, et al
    Transcriptomics Identify Thrombospondin-2 as a Biomarker for Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis.
    Hepatology. 2021 Jun 9. doi: 10.1002/hep.31995.
    >> Share

  54. CHO K, Ro SW, Lee HW, Moon H, et al
    YAP/TAZ suppress drug penetration into hepatocellular carcinoma via stromal activation.
    Hepatology. 2021 Jun 8. doi: 10.1002/hep.32000.
    >> Share

  55. CHEN B, Wu JX, Cheng SH, Wang LM, et al
    Phase II study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma.
    Hepatology. 2021 Jun 7. doi: 10.1002/hep.31993.
    >> Share

  56. JINDAL A, Jagdish RK
    Response to terlipressin plus albumin in Hepatorenal syndrome - Need a closer look!
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31990.
    >> Share

  57. WONG TC, Lee VH, Law AL, Pang HH, et al
    Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31992.
    >> Share

  58. YANG W, He H, Wang T, Su N, et al
    Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis.
    Hepatology. 2021 Jun 5. doi: 10.1002/hep.31987.
    >> Share

  59. MUHAMMAD KHAN M, Alejandra Luna-Cuadros M, Lau DTY, Sehrawat TS, et al
    Hepatology Highlights.
    Hepatology. 2021;73:2085-2088.
    >> Share

    May 2021
  60. VIVEIROS A, Schaefer B, Panzer M, Henninger B, et al
    MRI-based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of non-HFE Hemochromatosis Genes.
    Hepatology. 2021 May 28. doi: 10.1002/hep.31982.
    >> Share

  61. LEPORE A, Choy PM, Lee NC, Carella MA, et al
    Phosphorylation and stabilization of PIN1 by JNK promote intrahepatic cholangiocarcinoma growth.
    Hepatology. 2021 May 28. doi: 10.1002/hep.31983.
    >> Share

  62. JOHNSTON ME 2ND, Rivas MP, Nicolle D, Gorse A, et al
    Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient Derived Xenograft Models.
    Hepatology. 2021 May 26. doi: 10.1002/hep.31919.
    >> Share

  63. YI C, Chen L, Ling Z, Liu L, et al
    Lenvatinib Targets FGFR4 to Enhance Antitumor Immune Response of Anti-PD-1 in Hepatocellular Carcinoma.
    Hepatology. 2021 May 26. doi: 10.1002/hep.31921.
    >> Share

  64. SUN LY, Hu JY, Liang L, Tong XM, et al
    Letter to the Editor: Is Male Gender Associated with Increased Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis?
    Hepatology. 2021 May 22. doi: 10.1002/hep.31916.
    >> Share

  65. JOHN BV, Deng Y, Martin P, Levy C, et al
    Response to "Is Male Gender Associated with Increased Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis?"
    Hepatology. 2021 May 22. doi: 10.1002/hep.31917.
    >> Share

  66. MEHTA G, Jalan R
    The 'Alter Ego' of Albumin in Cirrhosis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31908.
    >> Share

  67. BAJAJ JS, Garcia-Tsao G, Reddy KR, O'Leary JG, et al
    Admission urinary and serum metabolites predict renal outcomes in hospitalized patients with cirrhosis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31907.
    >> Share

  68. JANSSON H, Sparrelid E
    Letter to the Editor: The role of surgery in multiple intrahepatic cholangiocarcinoma should not be dismissed without further analysis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31905.
    >> Share

  69. LAMARCA A, Santos-Laso A, Utpatel K, La Casta A, et al
    Reply to (20-1119.R1) Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation.
    Hepatology. 2021 May 17. doi: 10.1002/hep.31904.
    >> Share

  70. PEISELER M, Tacke F
    An unexpected line of defense: hepatoprotective eosinophils in ischemia-reperfusion injury.
    Hepatology. 2021 May 11. doi: 10.1002/hep.31895.
    >> Share

  71. VALSAN A, Verma N, Singh V
    Non-invasive differentiation of porto-sinusoidal vascular disease and cirrhosis: The Devil is in the details!
    Hepatology. 2021 May 11. doi: 10.1002/hep.31896.
    >> Share

  72. ELKRIEF L, Lazareth M, Rautou PE
    Reply to: "Non-invasive differentiation of porto-sinusoidal vascular disease and cirrhosis: The Devil is in the details!"
    Hepatology. 2021 May 11. doi: 10.1002/hep.31894.
    >> Share

  73. DICHTEL LE
    The GLP-1 Receptor Agonist Semaglutide for the Treatment of Nonalcoholic Steatohepatitis.
    Hepatology. 2021 May 6. doi: 10.1002/hep.31886.
    >> Share

  74. BIGGINS SW, Angeli P, Garcia-Tsao G, Gines P, et al
    Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
    Hepatology. 2021 May 3. doi: 10.1002/hep.31884.
    >> Share

  75. LIU Y, Dou X, Zhou WY, Ding M, et al
    Hepatic SENP2 Controls Systemic Metabolism via SUMOylation-dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Hepatology. 2021 May 2. doi: 10.1002/hep.31881.
    >> Share

  76. BUCKHOLZ A, Jesudian A, Sehrawat TS, Sehrawat O, et al
    Hepatology Highlights.
    Hepatology. 2021;73:1627-1630.
    >> Share


  77. Seeking Editor for Hepatology Communications.
    Hepatology. 2021;73:i.
    >> Share

    April 2021
  78. SHENG J, Kohno S, Okada N, Okahashi N, et al
    Treatment of RB1-intact hepatocellular carcinoma with CDK4/6 inhibitor combination therapy.
    Hepatology. 2021 Apr 30. doi: 10.1002/hep.31872.
    >> Share

  79. BUCKARMA E, Smoot R
    Hepatocytes Induce Change in Their Neighbors by YAP-ing at Them.
    Hepatology. 2021 Apr 30. doi: 10.1002/hep.31874.
    >> Share

  80. ISHIKAWA T, Sasaki R, Matsuda T, Saeki I, et al
    Successful Management with Dual Therapy of Lenvatinib and Macitentan for Hepatocellular Carcinoma with Portopulmonary Hypertension.
    Hepatology. 2021 Apr 26. doi: 10.1002/hep.31865.
    >> Share

  81. LUO Y, Gao Y, Liu W, Yang Y, et al
    MYC-Protein Arginine Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Hepatology. 2021 Apr 25. doi: 10.1002/hep.31864.
    >> Share

  82. YANG X, Sun D, Xiang H, Wang S, et al
    Hepatocyte SH3RF2 Deficiency is a Key Aggravator for Nonalcoholic Fatty Liver Disease.
    Hepatology. 2021 Apr 24. doi: 10.1002/hep.31863.
    >> Share

  83. LIU D, Pang J, Shao W, Gu J, et al
    Hepatic fibroblast growth factor 21 is involved in mediating functions of liraglutide in mice with dietary challenge.
    Hepatology. 2021 Apr 13. doi: 10.1002/hep.31856.
    >> Share

  84. XU X, Ye L, Zhang Q, Shen H, et al
    Group-2 Innate Lymphoid Cells Promote Hepatocellular Carcinoma Progression via CXCL2-Neutrophil Induced Immunosuppression.
    Hepatology. 2021 Apr 8. doi: 10.1002/hep.31855.
    >> Share

  85. SUN D, Yang X, Wu B, Zhang XJ, et al
    Therapeutic Potential of G Protein-Coupled Receptors against Nonalcoholic Steatohepatitis.
    Hepatology. 2021 Apr 7. doi: 10.1002/hep.31852.
    >> Share

  86. WING-SUM CHEU J, Chak-Lui Wong C
    Mechanistic Rationales guiding Combination Hepatocellular Carcinoma Therapies involving Immune Checkpoint Inhibitors.
    Hepatology. 2021 Apr 3. doi: 10.1002/hep.31840.
    >> Share

  87. KOVALIC AJ, Huang G, Thuluvath PJ, Satapathy SK, et al
    Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis.
    Hepatology. 2021;73:1521-1530.
    >> Share

  88. FU Y, Zhu R, Bai T, Han P, et al
    Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.
    Hepatology. 2021;73:1509-1520.
    >> Share

  89. KAUR SP, Trivedi H, Lau DTY, Bamidele AO, et al
    Hepatology Highlights.
    Hepatology. 2021;73:1245-1247.
    >> Share


  90. Seeking Editor for Hepatology Communications.
    Hepatology. 2021;73:i.
    >> Share

    March 2021
  91. NINA KIM H, Newcomb CW, Carbonari DM, Roy JA, et al
    Risk of Hepatocellular Carcinoma with Hepatitis B Viremia among HIV/Hepatitis B Virus-Coinfected Persons in North America.
    Hepatology. 2021 Mar 29. doi: 10.1002/hep.31839.
    >> Share

  92. BOERNER T, Drill E, Pak LM, Nguyen B, et al
    Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
    Hepatology. 2021 Mar 25. doi: 10.1002/hep.31829.
    >> Share

  93. DOURTHE C, Julien C, Di Tommaso S, Dupuy JW, et al
    Proteomic profiling of hepatocellular adenomas paves the way to new diagnostic and prognostic approaches.
    Hepatology. 2021 Mar 23. doi: 10.1002/hep.31826.
    >> Share

  94. BLOOM PP, Matherly S, Kumar S, Koh C, et al
    Professional Use of Social Media by Hepatology Providers.
    Hepatology. 2021 Mar 20. doi: 10.1002/hep.31824.
    >> Share

  95. SALEM R, Johnson GE, Kim E, Riaz A, et al
    Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study.
    Hepatology. 2021 Mar 19. doi: 10.1002/hep.31819.
    >> Share

  96. YASUDO H, Ando T, Maehara A, Ando T, et al
    A possible association between a novel NLRP1 mutation and an autoinflammatory disease involving liver cirrhosis.
    Hepatology. 2021 Mar 19. doi: 10.1002/hep.31818.
    >> Share

  97. ZHAO Y, Wang J, Liu WN, Fong SY, et al
    Analysis and validation of human targets and treatments using a hepatocellular carcinoma-immune humanized mouse model.
    Hepatology. 2021 Mar 18. doi: 10.1002/hep.31812.
    >> Share

  98. LEE YT, Wang JJ, Luu M, Tseng HR, et al
    State-Level Hepatocellular Carcinoma Incidence and Association with Obesity and Physical Activity in the United States.
    Hepatology. 2021 Mar 17. doi: 10.1002/hep.31811.
    >> Share

  99. WADA Y, Shimada M, Yamamura K, Toshima T, et al
    A transcriptomic signature for risk-stratification and recurrence prediction in intrahepatic cholangiocarcinoma.
    Hepatology. 2021 Mar 16. doi: 10.1002/hep.31803.
    >> Share

  100. SANO A, Kakazu E, Hamada S, Inoue J, et al
    Steatotic hepatocytes release mature VLDL via methionine and tyrosine metabolism in a Keap1-Nrf2 dependent manner.
    Hepatology. 2021 Mar 16. doi: 10.1002/hep.31808.
    >> Share

  101. ALEXOPOULOS AS, Crowley MJ, Wang Y, Moylan CA, et al
    Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2021 Mar 16. doi: 10.1002/hep.31806.
    >> Share

  102. MEUNIER L, Hirsch TZ, Caruso S, Imbeaud S, et al
    DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.
    Hepatology. 2021 Mar 13. doi: 10.1002/hep.31796.
    >> Share

  103. WU H, Xu X, Zheng A, Wang W, et al
    TIPE1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of ASK1.
    Hepatology. 2021 Mar 13. doi: 10.1002/hep.31801.
    >> Share

  104. BALDASSARRE M, Naldi M, Zaccherini G, Bartoletti M, et al
    Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications.
    Hepatology. 2021 Mar 12. doi: 10.1002/hep.31798.
    >> Share

  105. SATHIYAPALAN A, Legault K, van der Pol CB, Meyers BM, et al
    Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated with Lenvatinib.
    Hepatology. 2021 Mar 11. doi: 10.1002/hep.31794.
    >> Share

  106. SONG M, He J, Pan QZ, Yang J, et al
    Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression.
    Hepatology. 2021 Mar 8. doi: 10.1002/hep.31792.
    >> Share

  107. PONZIANI FR, Gasbarrini A, Pompili M
    Letter to the Editor. Restructuring the Gut Microbiota of Cirrhotic Patients after HCV Eradication: a Matter of Time?
    Hepatology. 2021 Mar 5. doi: 10.1002/hep.31784.
    >> Share


  108. Seeking Editor for Hepatology Communications.
    Hepatology. 2021;73:i.
    >> Share

  109. HANIF H, Ali MJ, Chen HW, Lau DTY, et al
    Hepatology Highlights.
    Hepatology. 2021;73:877-880.
    >> Share

  110. BLOOM PP, Meyerowitz EA, Reinus Z, Daidone M, et al
    Liver Biochemistries in Hospitalized Patients With COVID-19.
    Hepatology. 2021;73:890-900.
    >> Share

  111. MCHENRY SA, Davidson NO
    Ceramide Salvage, Gut Mucosal Immunoglobulin A Signaling, and Diet-Induced NASH.
    Hepatology. 2021;73:884-886.
    >> Share

  112. MELLINGER J, Winder GS, Fernandez AC
    Measuring the Alcohol in Alcohol-Associated Liver Disease: Choices and Challenges for Clinical Research.
    Hepatology. 2021;73:1207-1212.
    >> Share

  113. WEGERMANN K, Suzuki A, Mavis AM, Abdelmalek MF, et al
    Tackling Nonalcoholic Fatty Liver Disease: Three Targeted Populations.
    Hepatology. 2021;73:1199-1206.
    >> Share

  114. PAPAROUPA M, Schrader J, Jung C, Boenisch O, et al
    Bilateral Hematothorax Without Hematemesis-An Unusual Presentation of Variceal Bleeding.
    Hepatology. 2021;73:1233-1235.
    >> Share

  115. GODBEE M, Jakate S, Eswaran S
    A Case of Electronic Nicotine Delivery Systems (ENDS) Liver Injury.
    Hepatology. 2021;73:1230-1232.
    >> Share

  116. YOUNOSSI ZM, Rinella ME, Sanyal AJ, Harrison SA, et al
    From NAFLD to MAFLD: Implications of a Premature Change in Terminology.
    Hepatology. 2021;73:1194-1198.
    >> Share

  117. PROTCHENKO O, Baratz E, Jadhav S, Li F, et al
    Iron Chaperone Poly rC Binding Protein 1 Protects Mouse Liver From Lipid Peroxidation and Steatosis.
    Hepatology. 2021;73:1176-1193.
    >> Share

    February 2021
  118. NEWBERRY EP, Hall Z, Xie Y, Molitor EA, et al
    Liver specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis and hepatocellular cancer.
    Hepatology. 2021 Feb 27. doi: 10.1002/hep.31771.
    >> Share

  119. CHIU M, Garabon J, Chen L, Karp N, et al
    Mevalonic Aciduria Associated with Intrahepatic Bile Duct Paucity.
    Hepatology. 2021 Feb 27. doi: 10.1002/hep.31778.
    >> Share

  120. SHIOTA J, Samuelson LC, Razumilava N
    Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet?
    Hepatology. 2021 Feb 26. doi: 10.1002/hep.31772.
    >> Share

  121. SU T, Huang M, Liao J, Lin S, et al
    Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis through m(6) A mRNA Methylation Dependent Mechanism.
    Hepatology. 2021 Feb 26. doi: 10.1002/hep.31766.
    >> Share

  122. JOHN BV, Aitcheson G, Schwartz KB, Shabbir Khakoo N, et al
    Male Gender is Associated with Higher Rates of Liver-related Mortality in Primary Biliary Cholangitis and Cirrhosis.
    Hepatology. 2021 Feb 26. doi: 10.1002/hep.31776.
    >> Share

  123. HUANG DQ, Yeo YH, Nguyen MH
    Letter to the Editor: HCC surveillance in cirrhosis patients: Is the real-world situation even worse than reported?
    Hepatology. 2021 Feb 22. doi: 10.1002/hep.31760.
    >> Share

  124. RICH NE, Parikh ND, Singal AG
    HCC Surveillance in Cirrhosis Patients: Room for Improvement.
    Hepatology. 2021 Feb 22. doi: 10.1002/hep.31762.
    >> Share

  125. YAMASHITA T, Koshikawa N, Shimakami T, Terashima T, et al
    Serum laminin gamma2 monomer as a novel diagnostic and predictive biomarker for hepatocellular carcinoma.
    Hepatology. 2021 Feb 20. doi: 10.1002/hep.31758.
    >> Share

  126. BARROW F, Khan S, Fredrickson G, Wang H, et al
    Microbiota-Driven Activation of Intrahepatic B Cells Aggravates Nonalcoholic Steatohepatitis through Innate and Adaptive Signaling.
    Hepatology. 2021 Feb 20. doi: 10.1002/hep.31755.
    >> Share

  127. QU C, He L, Yao N, Li J, et al
    Myofibroblast-specific Msi2 knockout inhibits hepatocellular carcinoma progression in a mouse model.
    Hepatology. 2021 Feb 20. doi: 10.1002/hep.31754.
    >> Share

  128. LAN T, Yu Y, Zhang J, Li H, et al
    Cordycepin Ameliorates Nonalcoholic Steatohepatitis via Activation of AMP-Activated Protein Kinase Signaling Pathway.
    Hepatology. 2021 Feb 12. doi: 10.1002/hep.31749.
    >> Share

  129. DAT NQ, Thuy LTT, Hieu VN, Hai H, et al
    6His-tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species.
    Hepatology. 2021 Feb 11. doi: 10.1002/hep.31752.
    >> Share

  130. YOU Z, Li Y, Wang Q, Zhao Z, et al
    The Clinical Significance of Hepatic CD69(+) CD103(+) CD8(+) Resident Memory T Cells in Autoimmune Hepatitis.
    Hepatology. 2021 Feb 8. doi: 10.1002/hep.31739.
    >> Share

  131. LAMARCA A, Santos-Laso A, Utpatel K, La Casta A, et al
    Reply to "Does multiple intrahepatic cholangiocarcinoma worsen prognosis as "M1" stage?"; multiple primaries vs liver metastases.
    Hepatology. 2021 Feb 7. doi: 10.1002/hep.31740.
    >> Share

  132. ROSENTHAL SB, Liu X, Ganguly S, Dhar D, et al
    Heterogeneity of hepatic stellate cells in a mouse model of non-alcoholic steatohepatitis (NASH).
    Hepatology. 2021 Feb 7. doi: 10.1002/hep.31743.
    >> Share

  133. ZHANG XF, Lv Y, Pawlik TM
    Letter to the editor: Does multiple intrahepatic cholangiocarcinoma worsen prognosis as "M1" stage?
    Hepatology. 2021 Feb 6. doi: 10.1002/hep.31741.
    >> Share

  134. KE W, Cai De L, Jian Nan S, Chun Nian W, et al
    Primary Hepatic Squamous Cell Carcinoma With MSI-H Shows Good Response to PD-1 Inhibitor as Adjuvant Therapy.
    Hepatology. 2021 Feb 5. doi: 10.1002/hep.31737.
    >> Share

  135. TAO J, Krutsenko Y, Moghe A, Singh S, et al
    Nrf2 and beta-catenin coactivation in hepatocellular cancer: Biological and therapeutic implications.
    Hepatology. 2021 Feb 2. doi: 10.1002/hep.31730.
    >> Share

  136. SANSOE G, Aragno M, Wong F
    Covid-19 and liver cirrhosis: focus on the non-classical renin-angiotensin system and implications for therapy.
    Hepatology. 2021 Feb 1. doi: 10.1002/hep.31728.
    >> Share


  137. Seeking Editor for Hepatology Communications.
    Hepatology. 2021;73:1.
    >> Share

  138. BUCKHOLZ A, Brown RS Jr, Parthasarathy G, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2021;73:475-478.
    >> Share

  139. KARDASHIAN A, Wilder J, Terrault NA, Price JC, et al
    Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action.
    Hepatology. 2021;73:811-820.
    >> Share

  140. DI GUGLIELMO MD, Perito ER
    To Juice or Not to Juice: Fatty Liver Repercussions for Infants.
    Hepatology. 2021;73:483-485.
    >> Share

  141. PIROLA CJ, Sookoian S
    NAFLD and Cardiometabolic Risk Factors: The Liver Fibrosis Trajectory Through the Lens of Biological Interactions.
    Hepatology. 2021;73:479-482.
    >> Share

  142. GEURTSEN ML, Santos S, Gaillard R, Felix JF, et al
    Associations Between Intake of Sugar-Containing Beverages in Infancy With Liver Fat Accumulation at School Age.
    Hepatology. 2021;73:560-570.
    >> Share

  143. TILG H, Adolph TE, Moschen AR
    Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.
    Hepatology. 2021;73:833-842.
    >> Share

  144. AL-NAAMANI N, Krowka MJ, Forde KA, Krok KL, et al
    Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
    Hepatology. 2021;73:726-737.
    >> Share

  145. JUNG YS, Stratton SA, Lee SH, Kim MJ, et al
    TMEM9-v-ATPase Activates Wnt/beta-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis.
    Hepatology. 2021;73:776-794.
    >> Share

  146. HU W, Zheng S, Guo H, Dai B, et al
    PLAGL2-EGFR-HIF-1/2alpha Signaling Loop Promotes HCC Progression and Erlotinib Insensitivity.
    Hepatology. 2021;73:674-691.
    >> Share

  147. ZUO Q, He J, Zhang S, Wang H, et al
    PPARgamma Coactivator-1alpha Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARgamma-Dependent WNT/beta-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis.
    Hepatology. 2021;73:644-660.
    >> Share

    January 2021
  148. KALASEKAR SM, Garrido-Laguna I, Evason KJ
    Immune Checkpoint Inhibitors in Novel Combinations for Hepatocellular Carcinoma.
    Hepatology. 2021 Jan 12. doi: 10.1002/hep.31706.
    >> Share

  149. CARACENI P, Vargas V, Sola E, Alessandria C, et al
    The use of Rifaximin in Patients with Cirrhosis.
    Hepatology. 2021 Jan 9. doi: 10.1002/hep.31708.
    >> Share

  150. LUCE E, Messina A, Duclos-Vallee JC, Dubart-Kupperschmitt A, et al
    Advanced techniques and awaited clinical applications for human pluripotent stem cell differentiation into hepatocytes.
    Hepatology. 2021 Jan 8. doi: 10.1002/hep.31705.
    >> Share

  151. WELLHONER F, Doscher N, Woelfl F, Vital M, et al
    Eradication of chronic HCV infection: improvement of dysbiosis only in patients without liver cirrhosis.
    Hepatology. 2021 Jan 7. doi: 10.1002/hep.31700.
    >> Share

  152. SATIYA J, Kaur SP, Lau DTY, Hejazifar N, et al
    Hepatology Highlights.
    Hepatology. 2021;73:1-3.
    >> Share

  153. JAESCHKE H, Ramachandran A
    Letter to the Editor: Does c-Jun N-Terminal Kinase Regulate Acetaminophen Hepatotoxicity by Modulating Nuclear Factor Erythroid 2-Related Factor 2-Dependent Genes or Mitochondrial Oxidant Stress?
    Hepatology. 2021;73:467-468.
    >> Share

  154. TANG X, Wang XJ
    REPLY.
    Hepatology. 2021;73:468-469.
    >> Share

  155. CHOI J, Lim YS
    REPLY.
    Hepatology. 2021;73:467.
    >> Share

  156. CASEY L, Aday A, Rule J, Lee WM, et al
    Letter to the Editor: Response to Letter Concerning Our Pregnancy Manuscript.
    Hepatology. 2021;73:465.
    >> Share

  157. NORTHUP PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, et al
    Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:366-413.
    >> Share

  158. SARKAR M, Brady CW, Fleckenstein J, Forde KA, et al
    Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:318-365.
    >> Share

  159. DE JONGHE S, Weinstock D, Aligo J, Washington K, et al
    Biopsy Pathology and Immunohistochemistry of a Case of Immune-Mediated Drug-Induced Liver Injury With Atabecestat.
    Hepatology. 2021;73:452-455.
    >> Share

  160. LEONIS MA, Miethke AG, Fei L, Maynor S, et al
    Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
    Hepatology. 2021;73:233-246.
    >> Share

  161. LI YJ, Phillips EJ, Dellinger A, Nicoletti P, et al
    Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
    Hepatology. 2021;73:268-281.
    >> Share

  162. MORENO E, Toussaint MJM, van Essen SC, Bongiovanni L, et al
    E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Hepatology. 2021;73:303-317.
    >> Share

  163. GU L, Zhu Y, Lin X, Lu B, et al
    The IKKbeta-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.
    Hepatology. 2021;73:160-174.
    >> Share

  164. ZHOU B, Liu C, Xu L, Yuan Y, et al
    N(6) -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes.
    Hepatology. 2021;73:91-103.
    >> Share

  165. CABALLERO-CAMINO FJ, Rivilla I, Herraez E, Briz O, et al
    Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
    Hepatology. 2021;73:186-203.
    >> Share

    December 2020
  166. PINATO DJ, Fessas P, Sapisochin G, Marron TU, et al
    Perspectives on the neoadjuvant use of immunotherapy in hepatocellular carcinoma.
    Hepatology. 2020 Dec 28. doi: 10.1002/hep.31697.
    >> Share

  167. ELKRIEF L, Lazareth M, Chevret S, Paradis V, et al
    Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension.
    Hepatology. 2020 Dec 21. doi: 10.1002/hep.31688.
    >> Share

  168. ANANIA FA, Dimick-Santos L, Mehta R, Toerner J, et al
    Nonalcoholic Steatohepatitis: Current Thinking from the Division of Hepatology and Nutrition at the Food and Drug Administration.
    Hepatology. 2020 Dec 19. doi: 10.1002/hep.31687.
    >> Share

  169. VIVEIROS A, Beliveau V, Panzer M, Schaefer B, et al
    Neurodegeneration in Hepatic and Neurologic Wilson Disease.
    Hepatology. 2020 Dec 14. doi: 10.1002/hep.31681.
    >> Share

  170. LIOU H, Mody K, Boyle AW, Keaveny AP, et al
    Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive Hepatocellular Carcinoma Resulting in Complete Pathologic Response.
    Hepatology. 2020 Dec 7. doi: 10.1002/hep.31675.
    >> Share

  171. KOUKOULIOTI E, Ziagaki A, Weber SN, Lammert F, et al
    Long-term colestyramine treatment prevents cholestatic attacks in refractory benign recurrent intrahepatic cholestasis type 1 disease.
    Hepatology. 2020 Dec 5. doi: 10.1002/hep.31671.
    >> Share

  172. KEISHAM A, Taneja S, Roy A, Singh V, et al
    ABIDE in NAFLD: A potential game changer in a select cohort of cirrhosis.
    Hepatology. 2020 Dec 4. doi: 10.1002/hep.31667.
    >> Share

  173. ANAND A, Pathak P, Shalimar
    Letter to the editor: ABIDE model for predicting decompensation in non-alcoholic fatty liver disease-related cirrhosis.
    Hepatology. 2020 Dec 3. doi: 10.1002/hep.31668.
    >> Share

  174. BUCKHOLZ A, Brown RS Jr, Trivedi H, Khan MM, et al
    Hepatology Highlights.
    Hepatology. 2020;72:1893-1896.
    >> Share

  175. NOUREDDIN N, Alkhouri N, Brown KA, Noureddin M, et al
    Driving Nonalcoholic Steatohepatitis Forward Using the FibroScan Aspartate Aminotransferase Score, But Obey the Traffic Lights.
    Hepatology. 2020;72:2228-2230.
    >> Share

  176. MEHTA N, Yao FY
    Reply.
    Hepatology. 2020;72:2243-2244.
    >> Share

  177. SELCK TJ, Bok J, Amintavakoli R
    Letter to the Editor: Do Weather and Sunlight Really Affect Alcohol Consumption?
    Hepatology. 2020;72:2239.
    >> Share

  178. VENTURA-COTS M, Abraldes JG, Bataller R
    Reply.
    Hepatology. 2020;72:2239-2240.
    >> Share

    November 2020
  179. SIMON TG, Chan AT, Huttenhower C
    Microbiome Biomarkers: One Step Closer in NAFLD-Cirrhosis.
    Hepatology. 2020 Nov 29. doi: 10.1002/hep.31660.
    >> Share

  180. HERNANDEZ-MEZA G, von Felden J, Gonzalez-Kozlova EE, Garcia-Lezana T, et al
    DNA methylation profiling of human hepatocarcinogenesis.
    Hepatology. 2020 Nov 25. doi: 10.1002/hep.31659.
    >> Share

  181. KHATUN M, Sur S, Steele R, Ray R, et al
    Inhibition of long noncoding RNA Linc-Pint by hepatitis C virus in infected hepatocytes enhances lipogenesis.
    Hepatology. 2020 Nov 24. doi: 10.1002/hep.31656.
    >> Share

  182. MOUSA OY, Juran BD, McCauley BM, Vesterhus MN, et al
    Bile Acid Profiles in Primary Sclerosing Cholangitis and their Ability to Predict Hepatic Decompensation.
    Hepatology. 2020 Nov 23. doi: 10.1002/hep.31652.
    >> Share

  183. SIMONETTO DA, Shah VH, Kamath PS
    Surgery in patients with cirrhosis: as much an art as science.
    Hepatology. 2020 Nov 21. doi: 10.1002/hep.31643.
    >> Share

  184. IOANNOU GN, Liang PS, Locke E, Green P, et al
    Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality.
    Hepatology. 2020 Nov 21. doi: 10.1002/hep.31649.
    >> Share

  185. LI S, Liu Y, Bai Y, Chen M, et al
    RHOF promotes hepatocellular carcinoma metastasis by altering the metabolic status of cancer cells via RAB3D.
    Hepatology. 2020 Nov 18. doi: 10.1002/hep.31641.
    >> Share

  186. RICH NE, Marrero JA, Singal AG
    Reply: Wang et al, "Should growth pattern of hepatocellular carcinoma be constant and homogenous?"
    Hepatology. 2020 Nov 18. doi: 10.1002/hep.31638.
    >> Share

  187. WANG H, Mao Y, Huang M
    Letter to the Editors: should growth pattern of hepatocellular carcinoma be constant and homogenous?
    Hepatology. 2020 Nov 18. doi: 10.1002/hep.31640.
    >> Share

  188. SETIAWAN VW, Rosen HR
    Stratification of residual risk of hepatocellular carcinoma following HCV clearance with DAA in patients with advanced fibrosis and cirrhosis.
    Hepatology. 2020 Nov 18. doi: 10.1002/hep.31639.
    >> Share

  189. GU X, Sun R, Chen L, Chu S, et al
    Neutral ceramidase mediates nonalcoholic steatohepatitis by regulating monounsaturated fatty acids and gut IgA(+) B cells.
    Hepatology. 2020 Nov 13. doi: 10.1002/hep.31628.
    >> Share

  190. KOKUDO T
    Evaluating Liver Function in Patients With Cirrhosis.
    Hepatology. 2020 Nov 13. doi: 10.1002/hep.31626.
    >> Share

  191. LOOMBA R
    MRI-PDFF treatment response criteria in nonalcoholic steatohepatitis.
    Hepatology. 2020 Nov 11. doi: 10.1002/hep.31624.
    >> Share

  192. HUO TI, Liu PH, Hsu CY
    Using circulating biomarkers to stage hepatocellular carcinoma: Pitfalls and limitations.
    Hepatology. 2020 Nov 10. doi: 10.1002/hep.31618.
    >> Share

  193. SUN L, Guan A, Liu M, Mao Y, et al
    Letter to the editor: Comment on "HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk".
    Hepatology. 2020 Nov 10. doi: 10.1002/hep.31621.
    >> Share

  194. LOOMBA R, Noureddin M, Kowdley KV, Kohli A, et al
    Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis due to NASH.
    Hepatology. 2020 Nov 10. doi: 10.1002/hep.31622.
    >> Share

  195. GAO J, Wei B, Liu M, Hirsova P, et al
    Endothelial p300 promotes portal hypertension and hepatic fibrosis through CCL2-mediated angiocrine signaling.
    Hepatology. 2020 Nov 7. doi: 10.1002/hep.31617.
    >> Share

  196. KURODA H, Abe T, Fujiwara Y, Nagasawa T, et al
    Contrast-enhanced ultrasonography-based hepatic perfusion for early prediction of prognosis in acute liver failure.
    Hepatology. 2020 Nov 5. doi: 10.1002/hep.31615.
    >> Share

  197. KRISHNAN MS, Rajan Kd A, Park J, Arjunan V, et al
    Genomic analysis of Vascular Invasion in Hepatocellular Carcinoma (HCC) Reveals Molecular Drivers and Predictive Biomarkers.
    Hepatology. 2020 Nov 3. doi: 10.1002/hep.31614.
    >> Share

  198. RUSSO NW, Brown RS Jr, Parthasarathy G, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2020;72:1505-1508.
    >> Share

  199. BANINI BA, P Kumar D, Cazanave S, Seneshaw M, et al
    Identification of a metabolic, transcriptomic and molecular signature of PNPLA3-mediated acceleration of steatohepatitis.
    Hepatology. 2020 Nov 1. doi: 10.1002/hep.31609.
    >> Share

  200. ALKHOURI N, Kohli A, Loomba R, Harrison SA, et al
    Maintaining Patient Safety and Data Integrity of Nonalcoholic Steatohepatitis Clinical Trials During the Severe Acute Respiratory Syndrome-Coronavirus 2 Pandemic.
    Hepatology. 2020;72:1509-1513.
    >> Share

  201. BERTOLINI A, van de Peppel IP, Bodewes FAJA, Moshage H, et al
    Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.
    Hepatology. 2020;72:1864-1872.
    >> Share

  202. CAVE MC
    Environmental Pollution and the Developmental Origins of Childhood Liver Disease.
    Hepatology. 2020;72:1518-1521.
    >> Share

  203. JAESCHKE H, Ramachandran A
    Pleiotropic Roles of Platelets and Neutrophils in Cell Death and Recovery During Acetaminophen Hepatotoxicity.
    Hepatology. 2020;72:1873-1876.
    >> Share

  204. SINGH S, Verma N, Singh V
    Letter to the Editor: MELD-Lactate-the New Kid on the Block.
    Hepatology. 2020;72:1883.
    >> Share

    October 2020
  205. LONG MT, Zhang X, Xu H, Liu CT, et al
    Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study.
    Hepatology. 2020 Oct 30. doi: 10.1002/hep.31608.
    >> Share

  206. XU Y, Zhu Y, Hu S, Xu Y, et al
    Hepatocyte nuclear factor 4alpha prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling.
    Hepatology. 2020 Oct 23. doi: 10.1002/hep.31604.
    >> Share

  207. STARLINGER P, Pereyra D, Hackl H, Ortmayr G, et al
    Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment during Hepatic Surgery.
    Hepatology. 2020 Oct 20. doi: 10.1002/hep.31601.
    >> Share

  208. LAMARCA A, Santos-Laso A, Utpatel K, La Casta A, et al
    Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system.
    Hepatology. 2020 Oct 18. doi: 10.1002/hep.31598.
    >> Share

  209. TAN HY, Wang N, Zhang C, Chan YT, et al
    LOXL4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis.
    Hepatology. 2020 Oct 17. doi: 10.1002/hep.31600.
    >> Share

  210. LI XJ, Li QL, Ju LG, Zhao C, et al
    Deficiency of histone methyltransferase SETD2 in liver leads to abnormal lipid metabolism and hepatocarcinoma.
    Hepatology. 2020 Oct 15. doi: 10.1002/hep.31594.
    >> Share

  211. BROWN SA, Izzy M, Watt KD
    Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underutilized Potential.
    Hepatology. 2020 Oct 12. doi: 10.1002/hep.31595.
    >> Share

  212. ALONSO S, Manzano ML, Gea F, Gutierrez ML, et al
    A model based on non-invasive markers predicts very low hepatocellular carcinoma risk after viral response in HCV-advanced fibrosis.
    Hepatology. 2020 Oct 6. doi: 10.1002/hep.31588.
    >> Share

  213. YUAN G, Yao J, Yu J, Xie X, et al
    Letter to the Editors: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.
    Hepatology. 2020 Oct 5. doi: 10.1002/hep.31590.
    >> Share

  214. WONG TC, Yan-Yue Fung J, Pang HH, Leung CK, et al
    Analysis of survival benefits of living vs. deceased donor liver transplant in high MELD and hepatorenal syndrome.
    Hepatology. 2020 Oct 2. doi: 10.1002/hep.31584.
    >> Share

  215. ANTKOWIAK M, Green RM
    Telomeres, p53, Hepatocyte Nuclear Factor 4alpha, and Liver Disease.
    Hepatology. 2020;72:1166-1168.
    >> Share

  216. LA MURA V, Villanueva C, Abraldes JG, Bosch J, et al
    Reply.
    Hepatology. 2020;72:1494-1495.
    >> Share

  217. KUNZMANN LK, Schoknecht T, Poch T, Henze L, et al
    Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC).
    Hepatology. 2020;72:1310-1326.
    >> Share

    September 2020
  218. CALZADILLA-BERTOT L, Vilar-Gomez E, Wong VW, Romero-Gomez M, et al
    ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis.
    Hepatology. 2020 Sep 25. doi: 10.1002/hep.31576.
    >> Share

  219. CHANDLER RJ, Venturoni LE, Liao J, Hubbard BT, et al
    Promoterless, nuclease-free genome editing confers a growth advantage for corrected hepatocytes in mice with methylmalonic acidemia.
    Hepatology. 2020 Sep 25. doi: 10.1002/hep.31570.
    >> Share

  220. OOSHIO T, Yamamoto M, Fujii K, Xin B, et al
    Hepatocyte MKK7 Contributes to Restoration of the Liver Parenchyma Following Injury.
    Hepatology. 2020 Sep 23. doi: 10.1002/hep.31565.
    >> Share

  221. ZHANG BH, Cai YS, Song JL, Lyu T, et al
    Letter to the Editor: Statin Reduces the Risk of Hepatocellular Carcinoma Development in CHB Patients.
    Hepatology. 2020 Sep 23. doi: 10.1002/hep.31563.
    >> Share

  222. GOH MJ, Sinn DH, Woo SY, Kim S, et al
    Statins and reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: Author's Reply.
    Hepatology. 2020 Sep 22. doi: 10.1002/hep.31567.
    >> Share

  223. CHEN D, Wu H, Feng X, Chen Y, et al
    DNA Methylation of CNRIP1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin-Dependent PKM2 Ubiquitination.
    Hepatology. 2020 Sep 21. doi: 10.1002/hep.31561.
    >> Share

  224. MAHMUD N, Fricker Z, Hubbard RA, Ioannou GN, et al
    Novel Risk Prediction Models for Post-Operative Mortality in Patients with Cirrhosis.
    Hepatology. 2020 Sep 16. doi: 10.1002/hep.31558.
    >> Share

  225. MARTIN N, Ziegler DV, Parent R, Bernard D, et al
    Hepatic Stellate Cell Senescence in Liver Tumorigenesis.
    Hepatology. 2020 Sep 15. doi: 10.1002/hep.31556.
    >> Share

  226. MORRIS JS, Hassan MM, Zohner YE, Wang Z, et al
    HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk.
    Hepatology. 2020 Sep 15. doi: 10.1002/hep.31555.
    >> Share

  227. YAZDANI HO, Kaltenmeier C, Morder K, Moon J, et al
    Exercise training decreases hepatic injury via changes in immune response to liver ischemia/reperfusion in mice.
    Hepatology. 2020 Sep 14. doi: 10.1002/hep.31552.
    >> Share

  228. VERMA M, Younossi Z
    Integrating Patient Reported Outcomes within Routine Hepatology Care: A Prompt to Action.
    Hepatology. 2020 Sep 12. doi: 10.1002/hep.31550.
    >> Share

  229. THOMSON MJ, Lok AS, Tapper EB
    Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis.
    Hepatology. 2020 Sep 10. doi: 10.1002/hep.31548.
    >> Share

  230. ZHEN S, Cai X
    Letter to Editor: Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides.
    Hepatology. 2020 Sep 7. doi: 10.1002/hep.31543.
    >> Share

  231. PIANO S, Gambino C, Vettore E, Calvino V, et al
    Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Hepatology. 2020 Sep 1. doi: 10.1002/hep.31529.
    >> Share

  232. PHIPPS MM, Barraza LH, LaSota ED, Sobieszczyk ME, et al
    Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort.
    Hepatology. 2020;72:807-817.
    >> Share

  233. DA BL, Im GY, Schiano TD
    Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Hepatology. 2020;72:1102-1108.
    >> Share

  234. KAPLAN A, Rosenblatt R, Buckholz A, Kumar S, et al
    Hepatology Highlights.
    Hepatology. 2020;72:791-793.
    >> Share

  235. JIANG X, Ding WX
    Acyl Coenzyme A Thioesterase 9: A Novel Target for Nonalcoholic Fatty Liver Disease by Shuttling Mitochondrial Short-Chain Fatty Acids?
    Hepatology. 2020;72:797-800.
    >> Share

  236. GUICCIARDI ME, Nakao Y, Gores GJ
    The Metabolic Sensor Adenosine Monophosphate-Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis.
    Hepatology. 2020;72:1139-1141.
    >> Share

  237. KUMAR M
    Reply.
    Hepatology. 2020;72:1160.
    >> Share

  238. WEISS TS, Melter M, Dayoub R
    Letter to the Editor: Does Augmenter of Liver Regeneration Deficiency Pave the Way for Nonalcoholic Steatohepatitis Progression?
    Hepatology. 2020;72:1156-1157.
    >> Share

  239. VERMA AK, Gandhi CR
    Reply.
    Hepatology. 2020;72:1157-1158.
    >> Share

    August 2020
  240. SCHWANTES-AN TH, Darlay R, Mathurin P, Masson S, et al
    Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors.
    Hepatology. 2020 Aug 27. doi: 10.1002/hep.31535.
    >> Share

  241. LOOMBA R, Ling L, Dinh DM, DePaoli AM, et al
    The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis.
    Hepatology. 2020 Aug 13. doi: 10.1002/hep.31523.
    >> Share

  242. BHUSHAN B, Molina L, Koral K, Stoops JW, et al
    Yap is crucial for CAR-driven hepatocyte proliferation, but not for induction of drug metabolism genes in mice.
    Hepatology. 2020 Aug 13. doi: 10.1002/hep.31521.
    >> Share

  243. LEUNG KK, James PD, Jaberi A, Hirschfield GM, et al
    Esophageal Stenting as Bridge Therapy to Direct Intrahepatic Portocaval Shunt for Refractory Variceal Bleeding.
    Hepatology. 2020 Aug 11. doi: 10.1002/hep.31519.
    >> Share

  244. KULKARNI AV, Sharma M, Kumar P, Gupta R, et al
    Midodrine for Hepatic Hydrothorax.
    Hepatology. 2020 Aug 8. doi: 10.1002/hep.31513.
    >> Share

  245. BANINI BA, Alwatari Y, Ogden N, Gershman E, et al
    Letter to Editor: Response to Commentary "Midodrine for Hepatic Hydrothorax".
    Hepatology. 2020 Aug 7. doi: 10.1002/hep.31512.
    >> Share

  246. LU L, Jiang J, Zhan M, Zhang H, et al
    Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
    Hepatology. 2020 Aug 7. doi: 10.1002/hep.31502.
    >> Share

  247. DEGASPERI E, Galmozzi E, Pelusi S, D'Ambrosio R, et al
    Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs.
    Hepatology. 2020 Aug 6. doi: 10.1002/hep.31500.
    >> Share

  248. GINDIN Y, Chung C, Jiang Z, Zhou JZ, et al
    A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Novel Drivers of Disease Progression in Primary Sclerosing Cholangitis.
    Hepatology. 2020 Aug 3. doi: 10.1002/hep.31488.
    >> Share

  249. VERNA EC, Serper M, Chu J, Corey K, et al
    Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.
    Hepatology. 2020 Aug 2. doi: 10.1002/hep.31491.
    >> Share

  250. WANGENSTEEN KJ, Chang KM
    Multiple roles for hepatitis B and C viruses and the host in the development of hepatocellular carcinoma.
    Hepatology. 2020 Aug 1. doi: 10.1002/hep.31481.
    >> Share

  251. TALAT A, Shah PA, Lau DTY, Russo NW, et al
    Hepatology Highlights.
    Hepatology. 2020;72:369-370.
    >> Share

  252. SERPER M, Cubell AW, Deleener ME, Casher TK, et al
    Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?
    Hepatology. 2020;72:723-728.
    >> Share

  253. WEN Y, Ju C
    MER Proto-Oncogene Tyrosine Kinase: A Novel Potential Target to Treat Nonalcoholic Steatohepatitis Fibrosis.
    Hepatology. 2020;72:772-774.
    >> Share

  254. SINHA RA, Bruinstroop E, Singh BK, Yen PM, et al
    Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
    Hepatology. 2020;72:770-771.
    >> Share

  255. GAWRIEH S, Kleiner DE, Chalasani N, Vanderbeck S, et al
    Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2020;72:785.
    >> Share

  256. WEI L, Chang PEJ, Anstee QM
    Reply.
    Hepatology. 2020;72:786.
    >> Share

  257. KWON HM, Hwang GS
    Reply.
    Hepatology. 2020;72:784.
    >> Share

  258. HUANG JF, Dai CY, Yu ML, Chuang WL, et al
    Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter.
    Hepatology. 2020;72:781.
    >> Share

    July 2020
  259. LV Y, Wang Z, Li K, Wang Q, et al
    Risk Stratification based on CLIF Consortium Acute Decompensation score in Patients with Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
    Hepatology. 2020 Jul 24. doi: 10.1002/hep.31478.
    >> Share

  260. SABERI B, Naik H, Overbey JR, Erwin AL, et al
    Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.
    Hepatology. 2020 Jul 18. doi: 10.1002/hep.31460.
    >> Share

  261. LISMAN T
    Hemostatic Changes of Acute Kidney Injury in Patients With Cirrhosis: What Do They Mean?
    Hepatology. 2020 Jul 4. doi: 10.1002/hep.31451.
    >> Share

  262. ZANETTO A, Rinder HM, Campello E, Saggiorato G, et al
    Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features.
    Hepatology. 2020 Jul 2. doi: 10.1002/hep.31443.
    >> Share

  263. WEI X, Zhao L, Ren R, Ji F, et al
    MiR-125b Loss Activated HIF1alpha/pAKT Loop, Leading to Trans-Arterial Chemoembolization Resistance in Hepatocellular Carcinoma.
    Hepatology. 2020 Jul 1. doi: 10.1002/hep.31448.
    >> Share

  264. WANG Y
    Letter to the Editor: Issues of Circular RNAs as MicroRNA Sponges.
    Hepatology. 2020;72:365.
    >> Share

  265. LI L, Wei Y, Wang H
    REPLY.
    Hepatology. 2020;72:366.
    >> Share

  266. HOOFNAGLE JH
    FXR Agonists as Therapy for Liver Disease.
    Hepatology. 2020;72:1-3.
    >> Share

  267. MALLAT A, Lotersztajn S
    Glutamate Signaling in Alcohol-associated Fatty Liver: "Pas de Deux".
    Hepatology. 2020;72:350-352.
    >> Share

  268. SU T, Iwakiri Y
    Endothelial Leukocyte Cell-Derived Chemotaxin 2/Tyrosine Kinase With Immunoglobulin-Like and Epidermal Growth Factor-Like Domains 1 Signaling in Liver Fibrosis.
    Hepatology. 2020;72:347-349.
    >> Share

  269. YANG JD, Mara KC, Gores GJ, Roberts LR, et al
    Reply.
    Hepatology. 2020;72:364-365.
    >> Share

  270. YANG JD, Mara KC, Gores GJ, Roberts LR, et al
    REPLY.
    Hepatology. 2020;72:362-363.
    >> Share

  271. ARASE Y, Kagawa T, Tanaka A
    Reply.
    Hepatology. 2020;72:360-361.
    >> Share

  272. LLEO A, Ma X, Gershwin ME, Invernizzi P, et al
    Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment?
    Hepatology. 2020;72:359-360.
    >> Share

    June 2020
  273. PAPATHEODORIDIS GV, Voulgaris T, Papatheodoridi M, Kim WR, et al
    Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine.
    Hepatology. 2020 Jun 30. doi: 10.1002/hep.31440.
    >> Share

  274. KIM BK, Kim SU
    Re: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection.
    Hepatology. 2020 Jun 29. doi: 10.1002/hep.31439.
    >> Share

  275. WU J, Gao W, Tang Q, Yu Y, et al
    M2 macrophage-derived exosomes facilitate hepatocarcinoma metastasis by transferring alphaM beta2 integrin to tumor cells.
    Hepatology. 2020 Jun 28. doi: 10.1002/hep.31432.
    >> Share

  276. XU M, Ge C, Zhu L, Qin Y, et al
    iRhom2 promotes hepatic steatosis by activating MAP3K7-dependent pathway.
    Hepatology. 2020 Jun 26. doi: 10.1002/hep.31436.
    >> Share

  277. BANINI BA, Alwatari Y, Stovall M, Ogden N, et al
    Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence-Based Review and Guidance.
    Hepatology. 2020 Jun 25. doi: 10.1002/hep.31434.
    >> Share

  278. AKBULUT S, Sahin TT, Yilmaz S
    Comment on Alpha-Fetoprotein Decrease from > 1.000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
    Hepatology. 2020 Jun 24. doi: 10.1002/hep.31433.
    >> Share

  279. KLOECKNER R, Galle PR, Bruix J
    Local and Regional Therapies for Hepatocellular Carcinoma.
    Hepatology. 2020 Jun 18. doi: 10.1002/hep.31424.
    >> Share

  280. KIM YS, Nam HJ, Han CY, Joo MS, et al
    LXRalpha activation inhibits autophagy and lipophagy in hepatocytes by dysregulating ATG4B and Rab-8B, reducing mitochondrial fuel oxidation.
    Hepatology. 2020 Jun 17. doi: 10.1002/hep.31423.
    >> Share

  281. RUSSO MW, Fix OK, Koteish AA, Duggan K, et al
    Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.
    Hepatology. 2020 Jun 17. doi: 10.1002/hep.31425.
    >> Share

  282. ZHANG J, Li Y, Liu Q, Huang Y, et al
    Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells.
    Hepatology. 2020 Jun 14. doi: 10.1002/hep.31418.
    >> Share

  283. ALFERINK LJ, Radjabzadeh D, Erler NS, Vojinovic D, et al
    Microbiomics, metabolomics, predicted metagenomics and hepatic steatosis in a population-based study of 1355 adults.
    Hepatology. 2020 Jun 12. doi: 10.1002/hep.31417.
    >> Share

  284. XIE C, Fang JH, Zhuang SM
    Reply to: Letter to the editor, "PDIA3P1 level could predict recurrence-free survival in hepatocellular carcinoma: reliable?" (HEP-20-0942).
    Hepatology. 2020 Jun 11. doi: 10.1002/hep.31300.
    >> Share

  285. MUNROE M, Niero EL, Fok WC, Vessoni AT, et al
    Telomere dysfunction activates p53 and represses HNF4alpha expression leading to impaired human hepatocyte development and function.
    Hepatology. 2020 Jun 9. doi: 10.1002/hep.31414.
    >> Share

  286. PFEIFFER RM, Rotman Y, O'Brien TR
    Genetic Determinants of Cirrhosis and Hepatocellular Carcinoma Due to Fatty Liver Disease: What's the Score?
    Hepatology. 2020 Jun 7. doi: 10.1002/hep.31413.
    >> Share

  287. ZHAO N, Dang H, Ma L, Martin SP, et al
    Intratumoral gammadelta T-cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma.
    Hepatology. 2020 Jun 5. doi: 10.1002/hep.31412.
    >> Share

  288. ABUD A, Maddur H, Salem R
    Management of symptomatic portal cavernoma cholangiopathy via transplenic portal vein recanalization and TIPS.
    Hepatology. 2020 Jun 5. doi: 10.1002/hep.31411.
    >> Share

  289. PRABHU A, Cargill T, Roberts N, Ryan JD, et al
    Systematic review of the clinical outcomes of iron reduction in Hereditary Hemochromatosis.
    Hepatology. 2020 Jun 4. doi: 10.1002/hep.31405.
    >> Share

  290. KUMAR K, Kulkarni AV
    Sodium-Glucose Cotransporter-2(SGLT2-I) inhibitor are not the magic pills for control of ascites in cirrhosis and diabetes.
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31399.
    >> Share

  291. PATEL K, Chung C, Myers RP
    Reply to HEP-20-0871 Letter to the Editors: Cilofexor in patients with non-alcoholic steatohepatitis (NASH): Is it really effective?
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31402.
    >> Share

  292. PATOULIAS D, Katsimardou A, Papadopoulos C, Doumas M, et al
    Letter to the Editor: Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes.
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31398.
    >> Share

  293. KARDASHIAN A, Ge J, McCulloch CE, Kappus MR, et al
    Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31406.
    >> Share

  294. JINDAL A, Sarin SK
    Letter to the Editors: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective?
    Hepatology. 2020 Jun 2. doi: 10.1002/hep.31400.
    >> Share

  295. THALJI L, Thalji NM, Heimbach JK, Ibrahim SH, et al
    Renal Function Parameters and Serum Sodium Enhance Prediction of Waitlist Outcomes in Pediatric Liver Transplantation.
    Hepatology. 2020 Jun 2. doi: 10.1002/hep.31397.
    >> Share

  296. LUCEY MR, Singal AK
    Integrated Treatment of Alcohol Use Disorder in Patients With Alcohol-Associated Liver Disease: An Evolving Story.
    Hepatology. 2020;71:1891-1893.
    >> Share

    May 2020
  297. CALVISI DF
    Schistoma mansoni and Hepatocellular Carcinoma: is it all about c-Jun and STAT3?
    Hepatology. 2020 May 28. doi: 10.1002/hep.31392.
    >> Share

  298. HALL Z, Chiarugi D, Charidemou E, Leslie J, et al
    Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma.
    Hepatology. 2020 May 27. doi: 10.1002/hep.31391.
    >> Share

  299. SMITH JL, Rodriguez TC, Mou H, Kwan SY, et al
    YAP1 withdrawal in hepatoblastoma drives therapeutic differentiation of tumor cells to functional hepatocyte-like cells.
    Hepatology. 2020 May 26. doi: 10.1002/hep.31389.
    >> Share

  300. GUNASEKARAN G, Bekki Y, Lourdusamy V, Schwartz M, et al
    Surgical Treatments of Hepatobiliary Cancers.
    Hepatology. 2020 May 21. doi: 10.1002/hep.31325.
    >> Share

  301. LLOVET JM, Villanueva A, Marrero JA, Schwartz M, et al
    Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference.
    Hepatology. 2020 May 20. doi: 10.1002/hep.31327.
    >> Share

  302. DEVARBHAVI H
    RE: Acute Liver Failure (ALF) in Pregnancy: How Much Is Pregnancy-Related? Casey et al. Hepatology 2020 Jan 28[Online ahead of print DOI: 10.1002/hep.31144.
    Hepatology. 2020 May 17. doi: 10.1002/hep.31323.
    >> Share

  303. CHU S, Sun R, Gu X, Chen L, et al
    Inhibition of sphingosine-1-phosphate-induced Th17 cells ameliorates alcoholic steatohepatitis in mice.
    Hepatology. 2020 May 17. doi: 10.1002/hep.31321.
    >> Share

  304. NEWTON KP, Lavine JE, Wilson L, Behling C, et al
    Alanine Aminotransferase and Gamma Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis.
    Hepatology. 2020 May 16. doi: 10.1002/hep.31317.
    >> Share

  305. GABR A, Kulik L, Mouli S, Riaz A, et al
    Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort.
    Hepatology. 2020 May 16. doi: 10.1002/hep.31318.
    >> Share

  306. VANDEL J, Dubois-Chevalier J, Gheeraert C, Derudas B, et al
    Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH).
    Hepatology. 2020 May 11. doi: 10.1002/hep.31312.
    >> Share

  307. WOLF E, Rich NE, Marrero JA, Parikh N, et al
    Utilization of hepatocellular carcinoma surveillance in patients with cirrhosis: A systematic review and meta-analysis.
    Hepatology. 2020 May 8. doi: 10.1002/hep.31309.
    >> Share

  308. FINN RS, Zhu AX
    Evolution of Systemic Therapy for Hepatocellular Carcinoma.
    Hepatology. 2020 May 7. doi: 10.1002/hep.31306.
    >> Share

  309. LI W
    Letter to the Editor: PDIA3P1 level could predict recurrence-free survival in hepatocellular carcinoma: reliable?
    Hepatology. 2020 May 7. doi: 10.1002/hep.31299.
    >> Share

  310. PISA JF, Brown RS Jr, Hirsova P, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2020;71:1527-1529.
    >> Share

  311. KAPLOWITZ N, Than TA, Win S
    Acetaminophen Hepatotoxicity: Strong Offense and Weakened Defense.
    Hepatology. 2020;71:1530-1532.
    >> Share

  312. RAEVENS S, Fallon MB
    PORTICO: First Randomized Controlled Trial of Vasomodulator Therapy in Portopulmonary Hypertension.
    Hepatology. 2020;71:1870-1872.
    >> Share

  313. HENSON JB, Roden M, Targher G, Corey KE, et al
    Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart.
    Hepatology. 2020;71:1867-1869.
    >> Share

  314. ABERG F, Farkkila M, Salomaa V, Jula A, et al
    REPLY.
    Hepatology. 2020;71:1888-1889.
    >> Share

  315. GOW P, Testro AG, Hey P, Sinclair M, et al
    Letter to the Editor: Moderate Alcohol Use in Fatty Liver Disease: Don't Throw the Cabernet Out With the Bathwater.
    Hepatology. 2020;71:1887-1888.
    >> Share

  316. MA Y, Brown PM, Rotman Y
    REPLY.
    Hepatology. 2020;71:1886-1887.
    >> Share

  317. GALMOZZI E
    Letter to the Editor: Does the HSD17B13 rs72613567 Splice Variant Actually Yield a New Type of Alternative Splicing?
    Hepatology. 2020;71:1885-1886.
    >> Share

  318. IZZY M, VanWagner LB, Lin G, Altieri M, et al
    Reply.
    Hepatology. 2020;71:1884-1885.
    >> Share

  319. ZHOU J, Zhou F, Wang W, Zhang XJ, et al
    Epidemiological Features of NAFLD From 1999 to 2018 in China.
    Hepatology. 2020;71:1851-1864.
    >> Share

  320. CHEN Y, Liu K, Zhang J, Hai Y, et al
    c-Jun NH2 -Terminal Protein Kinase Phosphorylates the Nrf2-ECH Homology 6 Domain of Nuclear Factor Erythroid 2-Related Factor 2 and Downregulates Cytoprotective Genes in Acetaminophen-Induced Liver Injury in Mice.
    Hepatology. 2020;71:1787-1801.
    >> Share

  321. GAO W, Jia Z, Tian Y, Yang P, et al
    HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
    Hepatology. 2020;71:1678-1695.
    >> Share

  322. FLEMING BD, Urban DJ, Hall MD, Longerich T, et al
    Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.
    Hepatology. 2020;71:1696-1711.
    >> Share

  323. XIE C, Zhang LZ, Chen ZL, Zhong WJ, et al
    A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance.
    Hepatology. 2020;71:1660-1677.
    >> Share

    April 2020
  324. BEYLS C, Haustermans K, Deroose CM, Pans S, et al
    Could autoimmune disease contribute to the abscopal effect in metastatic hepatocellular carcinoma?
    Hepatology. 2020 Apr 29. doi: 10.1002/hep.31186.
    >> Share

  325. FONDEVILA MF, Fernandez U, Gonzalez-Rellan MJ, Da Silva Lima N, et al
    The L-alpha-lysophosphatidylinositol/GPR55 system induces the development of non-alcoholic steatosis and steatohepatitis.
    Hepatology. 2020 Apr 23. doi: 10.1002/hep.31290.
    >> Share

  326. CHOI J, Jo C, Lim YS
    Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection.
    Hepatology. 2020 Apr 23. doi: 10.1002/hep.31289.
    >> Share

  327. MCGLYNN KA, Petrick JL, El-Serag HB
    Epidemiology of Hepatocellular Carcinoma.
    Hepatology. 2020 Apr 22. doi: 10.1002/hep.31288.
    >> Share

  328. KUMAR A
    Letter to the Editor: Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?
    Hepatology. 2020 Apr 22. doi: 10.1002/hep.31285.
    >> Share

  329. KARDASHIAN A, Agopian V
    Reply to: "Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?"
    Hepatology. 2020 Apr 20. doi: 10.1002/hep.31283.
    >> Share

  330. MAHMUD N, Asrani SK
    Defining (and refining) the role of the Model for End Stage Liver Disease-Lactate (MELD-LA) score in cirrhosis.
    Hepatology. 2020 Apr 20. doi: 10.1002/hep.31287.
    >> Share

  331. LU L, Jiang J, Zhan M, Zhang H, et al
    Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
    Hepatology. 2020 Apr 16. doi: 10.1002/hep.31279.
    >> Share

  332. FIX OK, Hameed B, Fontana RJ, Kwok RM, et al
    Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
    Hepatology. 2020 Apr 16. doi: 10.1002/hep.31281.
    >> Share

  333. ZHANG L, Tian R, Yao X, Zhang XJ, et al
    Milk Fat Globule-EGF Factor 8 improves Hepatic Steatosis and Inflammation.
    Hepatology. 2020 Apr 15. doi: 10.1002/hep.31277.
    >> Share

  334. MONTALVO-GORDON I, Chi-Cervera LA, Garcia-Tsao G
    Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) ameliorate ascites and peripheral edema in patients with cirrhosis and diabetes.
    Hepatology. 2020 Apr 15. doi: 10.1002/hep.31270.
    >> Share

  335. DAVE S, Park S, Murad MH, Barnard A, et al
    Comparative Effectiveness of Entecavir vs Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: a Systematic Review and Meta-analysis.
    Hepatology. 2020 Apr 10. doi: 10.1002/hep.31267.
    >> Share

  336. SERPER M, Weinberg EM, Cohen JB, Reese PP, et al
    Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation.
    Hepatology. 2020 Apr 8. doi: 10.1002/hep.31264.
    >> Share

  337. PRIMIGNANI M, Tosetti G, Tripodi A
    Thromboelastography guided blood product transfusion in cirrhosis with coagulopathy: real saving or just less waste?
    Hepatology. 2020 Apr 8. doi: 10.1002/hep.31263.
    >> Share

  338. KUMAR A, Sharma P, Arora A
    A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk-stratification after variceal bleeding.
    Hepatology. 2020 Apr 4. doi: 10.1002/hep.31254.
    >> Share

  339. LAPUMNUAYPOL K, Danford CJ, Lau DTY, Pisa JF, et al
    Hepatology Highlights.
    Hepatology. 2020;71:1143-1145.
    >> Share

  340. RATZIU V
    Timing Is Everything: Improving NASH Histology in Clinical Trials Should Not Be Rushed.
    Hepatology. 2020;71:1146-1149.
    >> Share

  341. WANG S, Friedman SL
    Taming the Savage Breast From Within: Transcription Factor 21, a Regulator of Stellate Cell Deactivation.
    Hepatology. 2020;71:1150-1153.
    >> Share

  342. HILSCHER MB, Shah VH
    Small but Mighty: Platelets in NASH and Other Chronic Liver Diseases.
    Hepatology. 2020;71:1501-1504.
    >> Share

  343. YKI-JARVINEN H
    Ceramides: A Cause of Insulin Resistance in Nonalcoholic Fatty Liver Disease in Both Murine Models and Humans.
    Hepatology. 2020;71:1499-1501.
    >> Share

  344. HAJIFATHALIAN K, Torabi Sagvand B, McCullough A
    Reply.
    Hepatology. 2020;71:1526.
    >> Share

  345. BRAILLON A
    Letter to the Editor: Modest Alcohol Consumption and Nonalcoholic Fatty Liver Disease: An Oxymoron?
    Hepatology. 2020;71:1525.
    >> Share

  346. CARVAO J, Jasmins L
    Letter to the Editor: Glomerular Filtration Rate Assessment in Liver Disease (GRAIL): Are We There Yet?
    Hepatology. 2020;71:1522-1523.
    >> Share

  347. KHALAF RT, Sokol RJ
    New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Hepatology. 2020;71:1486-1498.
    >> Share

  348. XIONG X, Kuang H, Liu T, Lin JD, et al
    A Single-Cell Perspective of the Mammalian Liver in Health and Disease.
    Hepatology. 2020;71:1467-1473.
    >> Share

  349. IBRAHIM SH, Jonas MM, Taylor SA, Gutierrez Sanchez LH, et al
    Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant.
    Hepatology. 2020;71:1474-1485.
    >> Share

  350. XIONG J, Liu T, Mi L, Kuang H, et al
    hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis.
    Hepatology. 2020;71:1228-1246.
    >> Share

  351. LIU J, Wu Z, Han D, Wei C, et al
    Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-kappaB/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.
    Hepatology. 2020;71:1262-1278.
    >> Share

  352. ADAMS JM, Huppert KA, Castro EC, Lopez MF, et al
    Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.
    Hepatology. 2020;71:1331-1349.
    >> Share

  353. CHEN F, Esmaili S, Rogers GB, Bugianesi E, et al
    Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.
    Hepatology. 2020;71:1213-1227.
    >> Share

  354. ZHANG C, Lin R, Li Z, Yang S, et al
    Immune Exhaustion of T Cells in Alveolar Echinococcosis Patients and Its Reversal by Blocking Checkpoint Receptor TIGIT in a Murine Model.
    Hepatology. 2020;71:1297-1315.
    >> Share

  355. SHIGETA K, Datta M, Hato T, Kitahara S, et al
    Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma.
    Hepatology. 2020;71:1247-1261.
    >> Share

    March 2020
  356. LIU Y, Yang W, VoPham T, Ma Y, et al
    Plant-based and animal-based low-carbohydrate diets and risk of hepatocellular carcinoma among US men and women.
    Hepatology. 2020 Mar 29. doi: 10.1002/hep.31251.
    >> Share

  357. QIN J, Wang H, Qin X, Zhang P, et al
    Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.
    Hepatology. 2020 Mar 27. doi: 10.1002/hep.31257.
    >> Share

  358. WANG J, Ma J, Nie H, Zhang XJ, et al
    Hepatic Regulator of G protein Signaling 5 Ameliorates NAFLD by Suppressing TAK1-JNK/p38 Signaling.
    Hepatology. 2020 Mar 19. doi: 10.1002/hep.31242.
    >> Share

  359. GELLERT-KRISTENSEN H, Richardson TG, Davey Smith G, Nordestgaard BG, et al
    Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population.
    Hepatology. 2020 Mar 19. doi: 10.1002/hep.31238.
    >> Share

  360. VATS R, Liu S, Zhu J, Mukhi D, et al
    Impaired bile secretion promotes hepatobiliary injury in Sickle Cell Disease.
    Hepatology. 2020 Mar 19. doi: 10.1002/hep.31239.
    >> Share

  361. LI CL, Ho MC, Lin YY, Tzeng ST, et al
    Cell-free virus-host chimera DNA from Hepatitis B virus integration sites as a circulating biomarker of hepatocellular cancer.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31230.
    >> Share

  362. SZE KM, Ho DW, Chiu YT, Tsui YM, et al
    HBV-TERT Promoter Integration Harnesses Host ELF4 Resulting in TERT Gene Transcription in Hepatocellular Carcinoma.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31231.
    >> Share

  363. SCHWACHA-EIPPER B, Minciuna I, Banz V, Dufour JF, et al
    Immunotherapy as a downstaging therapy for liver transplantation.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31234.
    >> Share

  364. ISAACS-TEN A, Echeandia M, Moreno-Gonzalez M, Brion A, et al
    Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability.
    Hepatology. 2020 Mar 13. doi: 10.1002/hep.31228.
    >> Share

  365. PEA A, Jamieson NB, Braconi C
    Biology and clinical application of regulatory RNAs in hepatocellular carcinoma.
    Hepatology. 2020 Mar 11. doi: 10.1002/hep.31225.
    >> Share

  366. NAGAI S, Kitajima T, Yeddula S, Salgia R, et al
    Effect of mandatory 6-month waiting period on waitlist and transplant outcomes in patients with hepatocellular carcinoma.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31223.
    >> Share

  367. PAN WM, Wang H, Zhang XF, Xu P, et al
    miR-210 participates in hepatic ischemia reperfusion injury by forming a negative feedback loop with SMAD4.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31221.
    >> Share

  368. LIU X, Liu J, Xiao W, Zeng Q, et al
    SIRT1 regulates N(6) -methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31222.
    >> Share

  369. LIEBER SR, Heller BJ, Howard CW, Sandler RS, et al
    Complications Associated with Anesthesia Services in Endoscopic Procedures Among Patients with Cirrhosis.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31224.
    >> Share

  370. FRANCIS H, Wu N, Alpini G, Meng F, et al
    Hepatocyte Autophagy: Maintaining a Toxic-Free Environment.
    Hepatology. 2020 Mar 9. doi: 10.1002/hep.31219.
    >> Share

  371. ZENG J, Wu D, Hu H, Young JAT, et al
    Activation of the liver X receptor pathway inhibits HBV replication in primary human hepatocytes.
    Hepatology. 2020 Mar 7. doi: 10.1002/hep.31217.
    >> Share

  372. TERKELSEN MK, Bendixen SM, Hansen D, Scott EAH, et al
    Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury.
    Hepatology. 2020 Mar 7. doi: 10.1002/hep.31215.
    >> Share

  373. AZAD AI, Krishnan A, Troop L, Li Y, et al
    Targeted Apoptosis Of Ductular Reactive Cells Reduces Hepatic Fibrosis In A Mouse Model of Cholestasis.
    Hepatology. 2020 Mar 3. doi: 10.1002/hep.31211.
    >> Share

  374. KARDASHIAN A, Florman SS, Haydel B, Ruiz RM, et al
    Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Hepatology. 2020 Mar 2. doi: 10.1002/hep.31210.
    >> Share

  375. PATEL K, Harrison SA, Elkashab M, Trotter JF, et al
    Cilofexor, a Nonsteroidal FXR Agonist, in Non-Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial.
    Hepatology. 2020 Mar 1. doi: 10.1002/hep.31205.
    >> Share

  376. JALAN-SAKRIKAR N, Schwartz RE, Amir M, Wedd J, et al
    Hepatology Highlights.
    Hepatology. 2020;71:771-773.
    >> Share

  377. STENDER S, Loomba R
    PNPLA3 Genotype and Risk of Liver and All-Cause Mortality.
    Hepatology. 2020;71:777-779.
    >> Share

  378. TANER T, Heimbach JK
    Something Wicked this Way Comes.
    Hepatology. 2020;71:1119-1121.
    >> Share

  379. WONG GL, Wong VW
    Reply.
    Hepatology. 2020;71:1134.
    >> Share

  380. LO GH
    Letter to the Editor: Could Variceal Screening Stratified by Liver/Spleen Stiffness Replace the Role of Endoscopy?
    Hepatology. 2020;71:1133.
    >> Share

  381. RIZVI S, Gores GJ
    The Two Faces of Relaxin in Cancer: Antitumor or Protumor?
    Hepatology. 2020;71:1117-1119.
    >> Share

  382. SUGIYAMA T
    Letter to the Editor: Bone Health and Denosumab Treatment in Autoimmune Liver Diseases: A Possible Involvement of Physical Activity.
    Hepatology. 2020;71:1131-1132.
    >> Share

  383. ARASE Y, Kagawa T
    Reply.
    Hepatology. 2020;71:1132-1133.
    >> Share

  384. YANG D, Yan J, Weng J
    Reply.
    Hepatology. 2020;71:1129.
    >> Share

  385. LU ZN, Han ZG
    Reply.
    Hepatology. 2020;71:1130-1131.
    >> Share

  386. WANG JB, Bai ZF, Xiao XH
    Letter to the Editor: Is Aristolochic Acid the Major Cause of Liver Cancer in China and Asia?
    Hepatology. 2020;71:1130.
    >> Share

  387. SPANN A, Yasodhara A, Kang J, Watt K, et al
    Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review.
    Hepatology. 2020;71:1093-1105.
    >> Share

  388. UNALP-ARIDA A, Ruhl CE
    Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.
    Hepatology. 2020;71:820-834.
    >> Share

  389. LU ZN, Luo Q, Zhao LN, Shi Y, et al
    The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
    Hepatology. 2020;71:929-942.
    >> Share

  390. AJMERA VH, Liu A, Singh S, Yachoa G, et al
    Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2020;71:849-860.
    >> Share

  391. DE CHIARA F, Thomsen KL, Habtesion A, Jones H, et al
    Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease.
    Hepatology. 2020;71:874-892.
    >> Share

  392. CHANG Y, Ryu S, Kim Y, Cho YK, et al
    Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.
    Hepatology. 2020;71:861-873.
    >> Share

  393. ABERG F, Puukka P, Salomaa V, Mannisto S, et al
    Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.
    Hepatology. 2020;71:835-848.
    >> Share

    February 2020
  394. ITOH S, Yoshizumi T, Yugawa K, Imai D, et al
    Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association with Vascular Formation.
    Hepatology. 2020 Feb 29. doi: 10.1002/hep.31206.
    >> Share

  395. SHEN Y, Malik SA, Amir M, Kumar P, et al
    Decreased Hepatocyte Autophagy Leads to Synergistic IL-1beta and TNF Mouse Liver Injury and Inflammation.
    Hepatology. 2020 Feb 28. doi: 10.1002/hep.31209.
    >> Share

  396. SAILLARD C, Schmauch B, Laifa O, Moarii M, et al
    Predicting survival after hepatocellular carcinoma resection using deep-learning on histological slides.
    Hepatology. 2020 Feb 28. doi: 10.1002/hep.31207.
    >> Share

  397. TU C, Xiong H, Hu Y, Wang W, et al
    CRLS1 ameliorates nonalcoholic steatohepatitis through ATF3 transcriptional inactivation.
    Hepatology. 2020 Feb 25. doi: 10.1002/hep.31202.
    >> Share

  398. ZHU Y, Kwong LN
    Insights into the origin of intrahepatic cholangiocarcinoma from mouse models.
    Hepatology. 2020 Feb 24. doi: 10.1002/hep.31200.
    >> Share

  399. ZERMATTEN MG, Fraga M, Moradpour D, Bertaggia Calderara D, et al
    Haemostatic alterations in cirrhotic patients: from primary haemostasis to fibrinolysis.
    Hepatology. 2020 Feb 23. doi: 10.1002/hep.31201.
    >> Share

  400. LEI Y, Hoogerland JA, Bloks VW, Bos T, et al
    Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia.
    Hepatology. 2020 Feb 21. doi: 10.1002/hep.31198.
    >> Share

  401. DING J, Zhao J, Huan L, Liu Y, et al
    Inflammation-induced LINC00665 increases the malignancy through activating PKR/NF-kappaB pathway in hepatocellular carcinoma.
    Hepatology. 2020 Feb 21. doi: 10.1002/hep.31195.
    >> Share

  402. PEERAPHATDIT TB, Nkomo VT, Naksuk N, Simonetto DA, et al
    Long-Term Outcomes After Transcatheter and Surgical Aortic Valve Replacement in Patients With Cirrhosis: A Guide for the Hepatologist.
    Hepatology. 2020 Feb 20. doi: 10.1002/hep.31193.
    >> Share

  403. SHARMA A, Verma AK, Kofron M, Kudira R, et al
    Lipopolysaccharide Reverses Hepatic Stellate Cell Activation via Modulation of cMyb, SMADs and C/EBP Transcription Factors.
    Hepatology. 2020 Feb 16. doi: 10.1002/hep.31188.
    >> Share

  404. VITALE A, Trevisani F, Farinati F, Cillo U, et al
    Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy.
    Hepatology. 2020 Feb 16. doi: 10.1002/hep.31187.
    >> Share

  405. CHATURANTABUT S, Shwartz A, Garnaas MK, LaBella K, et al
    Estrogen acts via estrogen receptor 2b to regulate hepatobiliary fate during vertebrate development.
    Hepatology. 2020 Feb 14. doi: 10.1002/hep.31184.
    >> Share

  406. GUARALDI G, Maurice JB, Marzolini C, Monteith K, et al
    New drugs for non-alcoholic steatohepatitis and HIV infection: great expectations with a great absent?
    Hepatology. 2020 Feb 13. doi: 10.1002/hep.31177.
    >> Share

  407. NAULT JC, Villanueva A
    Biomarkers for hepatobiliary cancers.
    Hepatology. 2020 Feb 11. doi: 10.1002/hep.31175.
    >> Share

  408. DEBES JD, Boonstra A, de Knegt RJ
    NAFLD-Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse.
    Hepatology. 2020 Feb 10. doi: 10.1002/hep.31170.
    >> Share

  409. BHAN I, Ting DT
    Re: "Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease".
    Hepatology. 2020 Feb 8. doi: 10.1002/hep.31169.
    >> Share

  410. JEFFREY GP, Gordon LG, Hill MM, Ramm GA, et al
    Liquid biopsies for Hepatocellular cancer and their potential in clinical practice.
    Hepatology. 2020 Feb 7. doi: 10.1002/hep.31168.
    >> Share

  411. KUMAR S, Verma AK, Rani R, Sharma A, et al
    Hepatic deficiency of augmenter of liver regeneration predisposes to nonalcoholic steatohepatitis and fibrosis.
    Hepatology. 2020 Feb 7. doi: 10.1002/hep.31167.
    >> Share

  412. NATARAJAN Y, Kramer JR, Yu X, Li L, et al
    Risk of Cirrhosis and Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease and Normal Liver Enzymes.
    Hepatology. 2020 Feb 5. doi: 10.1002/hep.31157.
    >> Share

  413. RICH NE, John BV, Parikh ND, Rowe I, et al
    Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31159.
    >> Share

  414. AHN JC, Teng PC, Chen PJ, Posadas E, et al
    Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31165.
    >> Share

  415. DEROO R, Trepo E, Holvoet T, De Pauw M, et al
    Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31164.
    >> Share

  416. JOPHLIN LL, Cao S, Shah VH
    The transcriptome of hepatic fibrosis revealed by single cell RNA sequencing.
    Hepatology. 2020 Feb 3. doi: 10.1002/hep.31155.
    >> Share

  417. NIEHAUS CE, Strunz B, Cornillet M, Falk CS, et al
    MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis.
    Hepatology. 2020 Feb 3. doi: 10.1002/hep.31153.
    >> Share

  418. KAPLAN A, Rosenblatt R, Russo NW, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2020;71:405-407.
    >> Share

  419. GUILLOT A, Tacke F
    The Unexpected Role of Neutrophils for Resolving Liver Inflammation by Transmitting MicroRNA-223 to Macrophages.
    Hepatology. 2020;71:749-751.
    >> Share

  420. PANDEY S
    Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials.
    Hepatology. 2020;71:763-764.
    >> Share

  421. HASSAN S, Sebastian S, Maharjan S, Lesha A, et al
    Liver-on-a-Chip Models of Fatty Liver Disease.
    Hepatology. 2020;71:733-740.
    >> Share

  422. SANDAHL TD, Laursen TL, Munk DE, Vilstrup H, et al
    The Prevalence of Wilson's Disease: An Update.
    Hepatology. 2020;71:722-732.
    >> Share

  423. ARASE Y, Tsuruya K, Hirose S, Ogiwara N, et al
    Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases.
    Hepatology. 2020;71:757-759.
    >> Share

  424. PENRICE D, Simonetto DA
    Nodular Regenerative Hyperplasia Associated With Primary Liver Malignancies.
    Hepatology. 2020;71:760-761.
    >> Share

  425. BAIGES A, Turon F, Simon-Talero M, Tasayco S, et al
    Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study.
    Hepatology. 2020;71:658-669.
    >> Share

  426. SCHUMACHER JD, Kong B, Wu J, Rizzolo D, et al
    Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development.
    Hepatology. 2020;71:670-685.
    >> Share

  427. ALLEN AM, Shah VH, Therneau TM, Venkatesh SK, et al
    The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
    Hepatology. 2020;71:510-521.
    >> Share

  428. ARORA V, Maiwall R, Rajan V, Jindal A, et al
    Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Hepatology. 2020;71:600-610.
    >> Share

    January 2020
  429. FENG A, Masadeh M, Murali AR
    Recurrent Isolated Hyperbilirubinemia from Drug-Induced Impaired Hepatic Bilirubin Uptake.
    Hepatology. 2020 Jan 31. doi: 10.1002/hep.31154.
    >> Share

  430. LIN FP, Ferrando AA, Dennis RA, Dunn MA, et al
    Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy.
    Hepatology. 2020 Jan 30. doi: 10.1002/hep.31148.
    >> Share

  431. YI Z, Deng M, Scott MJ, Fu G, et al
    IRG1/Itaconate Activates Nrf2 in Hepatocytes to Protect Against Liver Ischemia-Reperfusion Injury.
    Hepatology. 2020 Jan 30. doi: 10.1002/hep.31147.
    >> Share

  432. WALLACE D, Cowling T, PcPhail MJ, Brown SE, et al
    Assessing the time-dependent impact of performance status on outcomes after liver transplantation.
    Hepatology. 2020 Jan 22. doi: 10.1002/hep.31124.
    >> Share

  433. LOOMBA R, Neuschwander-Tetri BA, Sanyal A, Chalasani N, et al
    Multicenter validation of association between decline in MRI-PDFF and histologic response in nonalcoholic steatohepatitis.
    Hepatology. 2020 Jan 21. doi: 10.1002/hep.31121.
    >> Share

  434. FERNANDEZ-VARO G, Perramon M, Carvajal S, Oro D, et al
    Bespoken nanoceria: A new effective treatment in experimental hepatocellular carcinoma.
    Hepatology. 2020 Jan 21. doi: 10.1002/hep.31139.
    >> Share

  435. LA MURA V, Garcia-Guix M, Berzigotti A, Abraldes JG, et al
    A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk-stratification after variceal bleeding.
    Hepatology. 2020 Jan 20. doi: 10.1002/hep.31125.
    >> Share

  436. MA L, Li H, Hu J, Zheng J, et al
    Indole Alleviates Diet-induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell PFKFB3.
    Hepatology. 2020 Jan 17. doi: 10.1002/hep.31115.
    >> Share

  437. JIANG JX, Fish SR, Tomilov A, Li Y, et al
    Non-phagocytic Activation of NOX2 is Implicated in Progressive Non-alcoholic Steatohepatitis During Aging.
    Hepatology. 2020 Jan 17. doi: 10.1002/hep.31118.
    >> Share

  438. ANGELIDAKIS G, Krishnan S, Cabrera NL, Jiang Y, et al
    Virologic Impact of Radiotherapy in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma.
    Hepatology. 2020 Jan 16. doi: 10.1002/hep.31114.
    >> Share

  439. FABRELLAS N, Carol M, Palacio E, Aban M, et al
    Nursing care of patients with cirrhosis.
    Hepatology. 2020 Jan 16. doi: 10.1002/hep.31117.
    >> Share

  440. KOLB JM, Conzen K, Wachs M, Crossno J Jr, et al
    Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
    Hepatology. 2020 Jan 14. doi: 10.1002/hep.31111.
    >> Share

  441. RATZIU V, Sanyal A, Harrison SA, Wong VW, et al
    Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study.
    Hepatology. 2020 Jan 13. doi: 10.1002/hep.31108.
    >> Share

  442. ZHANG Z, Trippler M, Real CI, Werner M, et al
    Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes.
    Hepatology. 2020 Jan 11. doi: 10.1002/hep.31112.
    >> Share

  443. TANTAI X, Liu N, Wang J
    Letter to Editor: The Association Between Diabetes and Hepatocellular carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease.
    Hepatology. 2020 Jan 6. doi: 10.1002/hep.31099.
    >> Share

  444. FENG Z, Rong P, Wang W
    Hepatocellular Carcinoma Risk in Patients With NASH Cirrhosis and Diabetes: Insufficient for Individual Management.
    Hepatology. 2020 Jan 6. doi: 10.1002/hep.31100.
    >> Share

  445. LIAO Z, Chen L, Zhang X, Zhang H, et al
    PTPRepsilon Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-beta Receptor 1.
    Hepatology. 2020 Jan 6. doi: 10.1002/hep.31104.
    >> Share

  446. ZHU M, Li L, Lu T, Yoo H, et al
    Uncovering biological factors that regulate hepatocellular carcinoma growth using patient derived xenograft assays.
    Hepatology. 2020 Jan 3. doi: 10.1002/hep.31096.
    >> Share

  447. SHAH PA, Lau DTY, Russo NW, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2020;71:1-3.
    >> Share


  448. Seeking Editor for Hepatology.
    Hepatology. 2020;71.
    >> Share

  449. NEUSCHWANDER-TETRI BA
    Too Much Sugar-The Not-So-Sweet Reality of Its Impact on Our Health.
    Hepatology. 2020;71:377-379.
    >> Share

  450. THALHEIMER U
    Letter to the Editor: The Obsolescence of Sclerotherapy.
    Hepatology. 2020;71:393.
    >> Share

  451. CHEUNG AC, Walker DI, Juran BD, Miller GW, et al
    Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.
    Hepatology. 2020;71:352-362.
    >> Share

  452. SHANG L, Mashek DG
    The Underpinnings of PNPLA3-Mediated Fatty Liver Emerge.
    Hepatology. 2020;71:375-377.
    >> Share

  453. JANSSON-KNODELL CL, Gawrieh S, McIntyre AD, Liang T, et al
    Apolipoprotein B and PNPLA3 Double Heterozygosity in a Father-Son Pair With Advanced Nonalcoholic Fatty Liver Disease.
    Hepatology. 2020;71:383-385.
    >> Share

  454. BALOG S, Li Y, Ogawa T, Miki T, et al
    Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice.
    Hepatology. 2020;71:291-305.
    >> Share

  455. KWAN SY, Sheel A, Song CQ, Zhang XO, et al
    Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.
    Hepatology. 2020;71:275-290.
    >> Share

  456. LAITINEN TT, Vahtera J, Pahkala K, Magnussen CG, et al
    Childhood Socioeconomic Disadvantage and Risk of Fatty Liver in Adulthood: The Cardiovascular Risk in Young Finns Study.
    Hepatology. 2020;71:67-75.
    >> Share

  457. GELLERT-KRISTENSEN H, Nordestgaard BG, Tybjaerg-Hansen A, Stender S, et al
    High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant.
    Hepatology. 2020;71:56-66.
    >> Share

    December 2019
  458. JOB S, Rapoud D, Dos Santos A, Gonzalez P, et al
    Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma.
    Hepatology. 2019 Dec 25. doi: 10.1002/hep.31092.
    >> Share

  459. DONG ZR, Sun D, Yang YF, Zhou W, et al
    TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic Cleavage.
    Hepatology. 2019 Dec 22. doi: 10.1002/hep.31076.
    >> Share

  460. CHANDRAMOULI S, Lee WM, Lo J, Toomay S, et al
    Prophylactic Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhosis Management in Pregnancy.
    Hepatology. 2019 Dec 21. doi: 10.1002/hep.31081.
    >> Share

  461. GAO E, Cheema H, Waheed N, Mushtaq I, et al
    OSTalpha deficiency: A disorder with cholestasis, liver fibrosis and congenital diarrhea.
    Hepatology. 2019 Dec 21. doi: 10.1002/hep.31087.
    >> Share

  462. JI GOH M, Kim S, Woo SY, Sinn DH, et al
    Statins and reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: Author's Reply.
    Hepatology. 2019 Dec 20. doi: 10.1002/hep.31079.
    >> Share

  463. KARVAR S, Ansa-Addo EA, Suda J, Singh S, et al
    Moesin, an ERM family member, regulates hepatic fibrosis.
    Hepatology. 2019 Dec 20. doi: 10.1002/hep.31078.
    >> Share

  464. HUANG R, Wang J, Wu W, Yan X, et al
    Letter to the Editor: Statins and reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B.
    Hepatology. 2019 Dec 19. doi: 10.1002/hep.31080.
    >> Share

  465. DEVARBHAVI H
    Response to "Liver Transplantation for Acute Liver Failure Due to Dengue Fever" by Galante A et al. Hepatology. 2019;70:1863-65.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31074.
    >> Share

  466. YANG NB, Li GX, Chu JG, Wang YJ, et al
    Letter to the Editors: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in NAFLD Patients.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31075.
    >> Share

  467. HU ZQ, Zhou SL, Li J, Zhou ZJ, et al
    Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis.
    Hepatology. 2019 Dec 15. doi: 10.1002/hep.31068.
    >> Share

  468. D'AMICO G, Abraldes JG, Rebora P, Valsecchi MG, et al
    Ordinal Outcomes Are Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis.
    Hepatology. 2019 Dec 14. doi: 10.1002/hep.31070.
    >> Share

  469. HU Z, Liangqing D, Li S, Li Z, et al
    Splicing Regulator p54(nrb) /NONO Enhances Carcinogenesis Through Oncogenic Isoform Switch of BIN1 in Hepatocellular Carcinoma.
    Hepatology. 2019 Dec 9. doi: 10.1002/hep.31062.
    >> Share

  470. LI Z, Weller SG, Drizyte-Miller K, Chen J, et al
    Maturation of Lipophagic Organelles in Hepatocytes is Dependent Upon a Rab10-Dynamin-2 Complex.
    Hepatology. 2019 Dec 6. doi: 10.1002/hep.31059.
    >> Share


  471. 2019 Hepatology Referees (Volumes 69 and 70).
    Hepatology. 2019;70:2245-2250.
    >> Share

  472. PISA JF, Brown RS Jr, Yang LM, Lau DTY, et al
    Hepatology Highlights.
    Hepatology. 2019;70:1881-1884.
    >> Share

    November 2019
  473. LIU XL, Pan Q, Cao HX, Xin FZ, et al
    Lipotoxic Hepatocyte-Derived Exosomal miR-192-5p Activates Macrophages via Rictor/Akt/FoxO1 Signaling in NAFLD.
    Hepatology. 2019 Nov 28. doi: 10.1002/hep.31050.
    >> Share

  474. XIAO X, Dev S, Canali S, Bayer A, et al
    Endothelial Bmp2 knockout exacerbates hemochromatosis in Hfe knockout mice but not Bmp6 knockout mice.
    Hepatology. 2019 Nov 28. doi: 10.1002/hep.31048.
    >> Share

  475. GYORI GP, Pereyra D, Rumpf B, Hackl H, et al
    Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation.
    Hepatology. 2019 Nov 27. doi: 10.1002/hep.31047.
    >> Share

  476. ROGAL S, Youk A, Zhang H, Gellad WF, et al
    Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis.
    Hepatology. 2019 Nov 23. doi: 10.1002/hep.31042.
    >> Share

  477. YU H, Li M, He R, Fang P, et al
    MVP promotes hepatocellular carcinoma via targeting IRF2 and decreasing p53 activity.
    Hepatology. 2019 Nov 23. doi: 10.1002/hep.31045.
    >> Share

  478. OVEREEM AW, Li Q, Qiu YL, Carton-Garcia F, et al
    A molecular mechanism underlying genotype-specific intrahepatic cholestasis resulting from MYO5B mutations.
    Hepatology. 2019 Nov 21. doi: 10.1002/hep.31002.
    >> Share

  479. OCHIAI Y, Yamaguchi J, Kokuryo T, Yokoyama Y, et al
    Trefoil factor family 1 inhibits the development of hepatocellular carcinoma by regulating beta-catenin activation.
    Hepatology. 2019 Nov 16. doi: 10.1002/hep.31039.
    >> Share

  480. KOSHY AN, Farouque O, Calafiore P, Gow PJ, et al
    Diagnosis of Cirrhotic Cardiomyopathy: The Role of an Impaired Cardiac Reserve.
    Hepatology. 2019 Nov 11. doi: 10.1002/hep.31034.
    >> Share

  481. HWANG S, He Y, Xiang X, Seo W, et al
    Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets.
    Hepatology. 2019 Nov 9. doi: 10.1002/hep.31031.
    >> Share

  482. LEE BP, Vittinghoff E, Pletcher MJ, Dodge JL, et al
    Medicaid Policy and Liver Transplant for Alcohol-Related Liver Disease.
    Hepatology. 2019 Nov 8. doi: 10.1002/hep.31027.
    >> Share

  483. HAN G, Berhane S, Toyoda H, Bettinger D, et al
    Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31022.
    >> Share

  484. WANG X, Gao B
    gammadeltaT cells and CD1d, novel immune players in alcoholic and nonalcoholic steatohepatitis?
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31025.
    >> Share

  485. KUTKUT I, Rachwan RJ, Timsina LR, Ghabril MS, et al
    Pre-Liver Transplant Cardiac Catheterization is Associated with Low Rate of Myocardial Infarction and Cardiac Mortality.
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31023.
    >> Share

  486. LUK ST, Ng KY, Zhou L, Tong M, et al
    Deficiency in embryonic stem cell marker REX1 activates MKK6-dependent p38 MAPK signaling to drive hepatocarcinogenesis.
    Hepatology. 2019 Nov 4. doi: 10.1002/hep.31020.
    >> Share

  487. EATON JE, Vuppalanchi R, Reddy R, Sathapathy S, et al
    Liver Injury in Patients with Cholestatic Liver Disease Treated with Obeticholic Acid.
    Hepatology. 2019 Nov 4. doi: 10.1002/hep.31017.
    >> Share

  488. FANG AP, Long JA, Zhang YJ, Liu ZY, et al
    Serum bioavailable, rather than total, 25-hydroxyvitamin D levels are associated with hepatocellular carcinoma survival.
    Hepatology. 2019 Nov 2. doi: 10.1002/hep.31013.
    >> Share

  489. KANWAL F, Kramer J, Li L, Dai J, et al
    Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non-alcoholic Fatty Liver Disease.
    Hepatology. 2019 Nov 1. doi: 10.1002/hep.31014.
    >> Share

  490. AMIR M, Vora RS, Tafesh ZH, Jesudian A, et al
    Hepatology Highlights.
    Hepatology. 2019;70:1497-1499.
    >> Share

    October 2019
  491. ASRANI SK
    Accurate assessment of renal function in cirrhosis.
    Hepatology. 2019 Oct 25. doi: 10.1002/hep.31006.
    >> Share

  492. SYED-ABDUL MM, Parks EJ, Gaballah AH, Bingham K, et al
    First-in-class fatty acid synthase inhibitor TVB-2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities.
    Hepatology. 2019 Oct 20. doi: 10.1002/hep.31000.
    >> Share

  493. STICKEL F, Lutz P, Buch S, Nischalke HD, et al
    Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers.
    Hepatology. 2019 Oct 19. doi: 10.1002/hep.30996.
    >> Share

  494. SONG K, Kwon H, Han C, Chen W, et al
    YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis.
    Hepatology. 2019 Oct 14. doi: 10.1002/hep.30990.
    >> Share

  495. TANEJA V
    Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease.
    Hepatology. 2019 Oct 14. doi: 10.1002/hep.30992.
    >> Share

  496. LEUNG CON, Tong M, Chung KPS, Zhou L, et al
    Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma.
    Hepatology. 2019 Oct 14. doi: 10.1002/hep.30989.
    >> Share

  497. HYDE AM, Carbonneau M, Abraldes JG, Tandon P, et al
    Advanced Practice Providers: Raising Our Defenses Against the Rising Tide of Cirrhosis.
    Hepatology. 2019 Oct 12. doi: 10.1002/hep.30987.
    >> Share

  498. LIU F, Goh GB, Tiniakos D, Wee A, et al
    qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Oct 10. doi: 10.1002/hep.30986.
    >> Share

  499. FELLI E, Saviano A, Tripon S, Baumert TF, et al
    Letter to the Editor: Abdominal Surgery in Idiopathic Noncirrhotic Portal Hypertension: Is Preemptive TIPS Reducing Postoperative Complications?
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30985.
    >> Share

  500. POLI E, Kounis I, Guettier C, Verstuyft C, et al
    Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil.
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30984.
    >> Share

  501. SHAHEEN R, Alsahli S, Ewida N, Alzahrani F, et al
    Biallelic mutations in TTC26 (IFT56) cause severe biliary ciliopathy in humans.
    Hepatology. 2019 Oct 8. doi: 10.1002/hep.30982.
    >> Share

  502. HUANG R, Wang J, Zhang Z, Yan X, et al
    Letter to the Editor: Impact of non-alcoholic steatohepatitis on liver-related outcomes in chronic hepatitis B.
    Hepatology. 2019 Oct 6. doi: 10.1002/hep.30981.
    >> Share

  503. SUN Q, Zhang Z, Lu Y, Liu Q, et al
    Loss of Xanthine Oxidoreductase Potentiates Propagation of Hepatocellular Carcinoma Stem Cells.
    Hepatology. 2019 Oct 3. doi: 10.1002/hep.30978.
    >> Share

    September 2019
  504. LIU Y, Chen K, Li F, Gu Z, et al
    Probiotic LGG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice.
    Hepatology. 2019 Sep 30. doi: 10.1002/hep.30975.
    >> Share

  505. GOH MJ, Sinn DH, Kim S, Woo SY, et al
    Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Hepatology. 2019 Sep 25. doi: 10.1002/hep.30973.
    >> Share

  506. KARSDAL MA, Detlefsen S, Daniels SJ, Nielsen MJ, et al
    Is the total amount as important as localization and type of collagen in liver fibrosis due to steatohepatitis?
    Hepatology. 2019 Sep 25. doi: 10.1002/hep.30969.
    >> Share

  507. PERKONS NR, Kiefer RM, Noji MC, Pourfathi M, et al
    Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.
    Hepatology. 2019 Sep 25. doi: 10.1002/hep.30970.
    >> Share

  508. NAKANO Y, Kamiya A, Sumiyoshi H, Tsuruya K, et al
    A novel deactivation factor of fibrogenic hepatic stellate cells induces regression of liver fibrosis in mice.
    Hepatology. 2019 Sep 24. doi: 10.1002/hep.30965.
    >> Share

  509. KIM YC, Jung H, Seok S, Zhang Y, et al
    MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice.
    Hepatology. 2019 Sep 24. doi: 10.1002/hep.30966.
    >> Share

  510. QIU W, Wang B, Gao Y, Tian Y, et al
    Targeting HDAC6 Reprograms TH 17 Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma.
    Hepatology. 2019 Sep 20. doi: 10.1002/hep.30960.
    >> Share

  511. DUSZYNSKI CC, Avati V, Lapointe AP, Scholkmann F, et al
    Near infrared spectroscopy reveals brain hypoxia and cerebrovascular dysregulation in primary biliary cholangitis.
    Hepatology. 2019 Sep 19. doi: 10.1002/hep.30920.
    >> Share

  512. KUMAR A, Sharma P, Arora A
    Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Sep 18. doi: 10.1002/hep.30957.
    >> Share

  513. DA BL, Koh C, Heller T
    REPLY: Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Sep 18. doi: 10.1002/hep.30955.
    >> Share

  514. MATSUZAKA T, Kuba M, Koyasu S, Yamamoto Y, et al
    Hepatocyte Elovl6 determines ceramide acyl-chain length and hepatic insulin sensitivity in mice.
    Hepatology. 2019 Sep 17. doi: 10.1002/hep.30953.
    >> Share

  515. TORRES-HERNANDEZ A, Wang W, Nikiforov Y, Tejada K, et al
    gammadelta T cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming.
    Hepatology. 2019 Sep 17. doi: 10.1002/hep.30952.
    >> Share

  516. FANG J, Ji YX, Zhang P, Cheng L, et al
    Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
    Hepatology. 2019 Sep 17. doi: 10.1002/hep.30950.
    >> Share

  517. CHEN J, Du F, Dang Y, Li X, et al
    FGF19-mediated upregulation of SOX18 promotes hepatocellular carcinoma metastasis by transactivating FGFR4 and FLT4.
    Hepatology. 2019 Sep 16. doi: 10.1002/hep.30951.
    >> Share

  518. ASRANI SK, Jennings LW, Kim WR, Kamath P, et al
    MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List.
    Hepatology. 2019 Sep 16. doi: 10.1002/hep.30932.
    >> Share

  519. ZHONG W, Wei X, Hao L, Lin TD, et al
    Paneth cell dysfunction mediates alcoholic steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency.
    Hepatology. 2019 Sep 14. doi: 10.1002/hep.30945.
    >> Share

  520. LOOMBA R, Adams LA
    Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH.
    Hepatology. 2019 Sep 13. doi: 10.1002/hep.30946.
    >> Share

  521. KIM HB, Elisofon SA
    Hepatology Elsewhere.
    Hepatology. 2019 Sep 13. doi: 10.1002/hep.30935.
    >> Share

  522. GOUYA L, Ventura P, Balwani M, Bissell DM, et al
    EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
    Hepatology. 2019 Sep 12. doi: 10.1002/hep.30936.
    >> Share

  523. HUANG Z, Zhou JK, Wang K, Chen H, et al
    PDLIM1 inhibits tumor metastasis through activating Hippo signaling in hepatocellular carcinoma.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30930.
    >> Share

  524. DONG B, Zhou Y, Wang W, Scott J, et al
    Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30937.
    >> Share

  525. BI X, Deising A, Frenette C
    Acute Liver Failure from Exertional Heatstroke Can Result in Excellent Long-term Survival with Liver Transplantation.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30938.
    >> Share

  526. MOORING M, Fowl BH, Lum SZC, Liu Y, et al
    Hepatocyte Stress Increases Expression of YAP and TAZ in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Hepatology. 2019 Sep 10. doi: 10.1002/hep.30928.
    >> Share

  527. TARDELLI M, Bruschi FV, Fuchs CD, Claudel T, et al
    Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis.
    Hepatology. 2019 Sep 10. doi: 10.1002/hep.30929.
    >> Share

  528. YANG Z, Feng J, Xiao L, Chen X, et al
    Tumor-Derived PGLYRP2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma.
    Hepatology. 2019 Sep 3. doi: 10.1002/hep.30924.
    >> Share

    August 2019
  529. WONG TL, Ng KY, Vin Tan K, Chan LH, et al
    CRAF methylation by PRMT6 regulates aerobic glycolysis driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.
    Hepatology. 2019 Aug 30. doi: 10.1002/hep.30923.
    >> Share

  530. MATYAS C, Erdelyi K, Trojnar E, Zhao S, et al
    Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy.
    Hepatology. 2019 Aug 30. doi: 10.1002/hep.30916.
    >> Share

  531. BLASI A, Patel VC, Adelmeijer J, Azarian S, et al
    Mixed fibrinolytic phenotypes in decompensated cirrhosis and ACLF with hypofibrinolysis in those with complications and poor survival.
    Hepatology. 2019 Aug 29. doi: 10.1002/hep.30915.
    >> Share

  532. KWON HM, Moon YJ, Jung KW, Park YS, et al
    Appraisal of cardiac ejection fraction with liver disease severity: Implication in post-liver transplantation mortality.
    Hepatology. 2019 Aug 28. doi: 10.1002/hep.30913.
    >> Share

  533. BEUERS U, Hohenester S
    Fatigue in Primary Biliary Cholangitis: no Place for Rituximab.
    Hepatology. 2019 Aug 23. doi: 10.1002/hep.30906.
    >> Share

  534. MOHANTY SK, Lobeck I, Donnelly B, Dupree P, et al
    Rotavirus reassortant induced murine model of liver fibrosis parallels human biliary atresia.
    Hepatology. 2019 Aug 23. doi: 10.1002/hep.30907.
    >> Share

  535. PATRA T, Meyer K, Ray RB, Ray R, et al
    Hepatitis C virus mediated inhibition of miR-181c activates ATM signaling and promotes hepatocyte growth.
    Hepatology. 2019 Aug 10. doi: 10.1002/hep.30893.
    >> Share

  536. GUO WZ, Fang HB, Cao SL, Chen SY, et al
    Steap3 deficiency in hepatocytes protects the liver against ischemia/reperfusion injury by suppressing TAK1.
    Hepatology. 2019 Aug 8. doi: 10.1002/hep.30882.
    >> Share

  537. ZHOU Y, Dong B, Kim KH, Choi S, et al
    Vitamin D receptor activation in liver macrophages protects against hepatic endoplasmic reticulum stress in mice.
    Hepatology. 2019 Aug 5. doi: 10.1002/hep.30887.
    >> Share

  538. HIRSOVA P, Malhi H, Russo N, Shah PA, et al
    Hepatology Highlights.
    Hepatology. 2019;70:455-458.
    >> Share

    July 2019
  539. MANDORFER M, Kozbial K, Schwabl P, Chromy D, et al
    Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy.
    Hepatology. 2019 Jul 31. doi: 10.1002/hep.30885.
    >> Share

  540. CHOI S, Dong B, Lin CJ, Heo MJ, et al
    Methyl-sensing nuclear receptor Liver Receptor Homolog-1 regulates mitochondrial function in mouse hepatocytes.
    Hepatology. 2019 Jul 29. doi: 10.1002/hep.30884.
    >> Share

  541. KIM HD, Park S, Jeong S, Lee YJ, et al
    4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8(+) T cells in Hepatocellular Carcinoma.
    Hepatology. 2019 Jul 28. doi: 10.1002/hep.30881.
    >> Share

  542. ZIOGAS IA, van der Windt DJ, Wilson GC, Furlan A, et al
    Surgical Management of Ciliated Hepatic Foregut Cyst.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30877.
    >> Share

  543. MEHTA N, Dodge JL, Grab JD, Yao FY, et al
    National Experience on Down-staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP, and Wait Time.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30879.
    >> Share

  544. LUO F, Liao R
    Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: Benefit or Not.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30872.
    >> Share

  545. ZHANG XP, Gao YZ, Chen ZH, Cheng SQ, et al
    Reply to "Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: Benefit or Not".
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30873.
    >> Share

  546. IZZY M, VanWagner LB, Lin G, Altieri M, et al
    Redefining Cirrhotic Cardiomyopathy For The Modern Era.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30875.
    >> Share

  547. KYRITSI K, Chen L, O'Brien A, Francis H, et al
    Modulation of the TPH1/MAO-A/5HT/5HTR2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30880.
    >> Share

  548. CHOUDHARY NS, Saigal S, Soin AS
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jul 22. doi: 10.1002/hep.30869.
    >> Share

  549. LO GH
    Letter of Editor: Colder weather and fewer sunlight hours truly increase alcohol consumption and alcoholic cirrhosis ?
    Hepatology. 2019 Jul 19. doi: 10.1002/hep.30865.
    >> Share

  550. DA BL, Surana P, Kapuria D, Vittal A, et al
    Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Jul 18. doi: 10.1002/hep.30862.
    >> Share

  551. ALLER MA, Arias J, Blanco-Rivero J
    The porto-hepatic spectrum of cirrhotic encephalopathy.
    Hepatology. 2019 Jul 17. doi: 10.1002/hep.30860.
    >> Share

  552. MAIWALL R, Rao Pasupuleti SS, Bihari C, Rastogi A, et al
    Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.
    Hepatology. 2019 Jul 16. doi: 10.1002/hep.30859.
    >> Share

  553. YANG JD, Ahmed F, Mara KC, Addissie BD, et al
    Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.
    Hepatology. 2019 Jul 15. doi: 10.1002/hep.30858.
    >> Share

  554. CHOI HSJ, Brouwer WP, Zanjir WMR, de Man RA, et al
    Non-Alcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B.
    Hepatology. 2019 Jul 15. doi: 10.1002/hep.30857.
    >> Share

  555. MARRERO JA
    Obesity and Liver Disease: The New Era of Liver Transplantation.
    Hepatology. 2019 Jul 13. doi: 10.1002/hep.30854.
    >> Share

  556. BUBICI C, Lepore A, Papa S
    ASKing no more: the emerging role of DUSP12 in the regulation of hepatic lipid metabolism.
    Hepatology. 2019 Jul 12. doi: 10.1002/hep.30851.
    >> Share

  557. JIA X, Lu S, Zeng Z, Liu Q, et al
    Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma.
    Hepatology. 2019 Jul 12. doi: 10.1002/hep.30852.
    >> Share

  558. SIMONETTO DA, Kamath PS, Shah VH
    Assessing surgical risk in idiopathic portal hypertension: some answers, an extrapolation, and more questions.
    Hepatology. 2019 Jul 12. doi: 10.1002/hep.30847.
    >> Share

  559. WANG AY, Smith EZ, Sauer BG, Henry ZH, et al
    A pilot experience of endoscopic submucosal dissection of Barrett's dysplasia despite esophageal varices and decompensated cirrhosis.
    Hepatology. 2019 Jul 11. doi: 10.1002/hep.30850.
    >> Share

  560. MAJUMDAR A, Campos S, Gurusamy K, Pinzani M, et al
    Defining the minimum acceptable diagnostic accuracy of non-invasive fibrosis testing in cirrhosis: a decision analytic modelling study.
    Hepatology. 2019 Jul 11. doi: 10.1002/hep.30846.
    >> Share

  561. WU SH, Hsu JS, Chen HL, Chien MM, et al
    Plectin Mutations in Progressive Familial Intrahepatic Cholestasis.
    Hepatology. 2019 Jul 3. doi: 10.1002/hep.30841.
    >> Share

  562. MOUSA OY, Malhi H, Russo N, Jesudian A, et al
    Hepatology Highlights.
    Hepatology. 2019;70:1-4.
    >> Share

    June 2019
  563. CHOUDHARY NS, Saraf N, Saigal S, Soin AS, et al
    Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis.
    Hepatology. 2019 Jun 27. doi: 10.1002/hep.30837.
    >> Share

  564. FIRL DJ, Sasaki K, Agopian VG, Gorgen A, et al
    Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients.
    Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838.
    >> Share

  565. PAPATHEODORIDI AM, Chrysavgis L, Koutsilieris M, Chatzigeorgiou A, et al
    The role of senescence in the development of non-alcoholic fatty liver disease and progression to non-alcoholic steatohepatitis.
    Hepatology. 2019 Jun 23. doi: 10.1002/hep.30834.
    >> Share

  566. WANG Y, Wen H, Fu J, Cai L, et al
    Hepatocyte TRAF6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lys6- Linked Polyubiquitination of ASK1.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30822.
    >> Share

  567. KANWAL F, Kramer JR, Asch SM, Cao Y, et al
    Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30823.
    >> Share

  568. VILARINHO S, Mistry PK
    Exome Sequencing in Clinical Hepatology.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30826.
    >> Share

  569. LI J, Wang J, Yu S, Yuan G, et al
    Hepatocellular Carcinoma Surveillance In High-Risk Patients With Cirrhosis:Contrast-enhanced Ultrasound May Be A Choice.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30819.
    >> Share

  570. LIU R, Kang JD, Sartor RB, Sikaroodi M, et al
    Neuroinflammation in Murine Cirrhosis is Dependent on the Gut Microbiome and is Attenuated by Fecal Transplant.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30827.
    >> Share

  571. CAREY EJ, Lai JC, Sonnenday C, Tapper EB, et al
    A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30828.
    >> Share

  572. HUANG M, Kim HG, Zhong X, Dong C, et al
    Sesn3 protects against diet-induced nonalcoholic steatohepatitis in mice via suppression of the TGFbeta signal transduction.
    Hepatology. 2019 Jun 19. doi: 10.1002/hep.30820.
    >> Share

  573. DIMRI M, Humphries A, Laknaur A, Elattar S, et al
    Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma.
    Hepatology. 2019 Jun 19. doi: 10.1002/hep.30818.
    >> Share

  574. KLOMPENHOUWER AJ, Thomeer MGJ, Dinjens WNM, de Man RA, et al
    Phenotype or genotype: new decision-making dilemmas in hepatocellular adenoma.
    Hepatology. 2019 Jun 17. doi: 10.1002/hep.30812.
    >> Share

  575. RENNE SL, Woo HY, Allegra S, Rudini N, et al
    VETC (vessels encapsulating tumor clusters) is a powerful predictor of aggressive hepatocellular carcinoma.
    Hepatology. 2019 Jun 17. doi: 10.1002/hep.30814.
    >> Share

  576. FUJIWARA N, Singal AG, Hoshida Y
    Dose and duration of aspirin use to reduce incidental hepatocellular carcinoma.
    Hepatology. 2019 Jun 17. doi: 10.1002/hep.30813.
    >> Share

  577. NAULT JC, Martin Y, Caruso S, Hirsch TZ, et al
    Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma.
    Hepatology. 2019 Jun 17. doi: 10.1002/hep.30811.
    >> Share

  578. WINER BY, Gaska JM, Lipkowitz G, Bram Y, et al
    Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system.
    Hepatology. 2019 Jun 17. doi: 10.1002/hep.30815.
    >> Share

  579. ZHENG Q, Zhao J, Yu H, Zong H, et al
    Tumor-specific Transcripts are Frequently Expressed in Hepatocellular Carcinoma with Clinical Implication and Potential Function.
    Hepatology. 2019 Jun 7. doi: 10.1002/hep.30805.
    >> Share

  580. GALANTE A, Adeyi O, Lau L, Humar A, et al
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jun 4. doi: 10.1002/hep.30803.
    >> Share

  581. WU H, Yang TY, Li Y, Ye WL, et al
    TRAF6 promotes hepatocarcinogenesis by interacting with HDAC3 to enhance c-Myc gene expression and protein stability.
    Hepatology. 2019 Jun 3. doi: 10.1002/hep.30801.
    >> Share

  582. SURI JS, Ezaz G, Lau DTY, Kulai TB, et al
    Hepatology Highlights.
    Hepatology. 2019;69:2311-2314.
    >> Share

    May 2019
  583. KUMAR M, Ahmad J, Maiwall R, Choudhury A, et al
    Thromboelastography-Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial.
    Hepatology. 2019 May 31. doi: 10.1002/hep.30794.
    >> Share

  584. QIN G, Tu X, Li H, Cao P, et al
    lncRNA PSTAR Promotes p53 Signaling by Inhibiting hnRNP K deSUMOylation and Suppresses Hepatocellular Carcinoma.
    Hepatology. 2019 May 30. doi: 10.1002/hep.30793.
    >> Share

  585. WEI Y, Chen X, Liang C, Ling Y, et al
    A Noncoding Regulatory RNAs Network Driven by Circ-CDYL Acts Specifically in the Early Stages Hepatocellular Carcinoma.
    Hepatology. 2019 May 30. doi: 10.1002/hep.30795.
    >> Share

  586. WANG CY, Xiao X, Bayer A, Xu Y, et al
    Ablation of hepatocyte Smad1, Smad5 and Smad8 causes severe tissue iron loading and liver fibrosis in mice.
    Hepatology. 2019 May 24. doi: 10.1002/hep.30780.
    >> Share

  587. TERZIROLI BERETTA-PICCOLI B, Thompson R, Foskett P, Cerny A, et al
    A novel heterozygous ABCB4, RUNDC3B and ABCB1 deletion associated with severe cholestatic liver disease in adulthood.
    Hepatology. 2019 May 24. doi: 10.1002/hep.30783.
    >> Share

  588. SERPER M, Kaplan DE, Shults J, Reese PP, et al
    Quality measures, all-cause mortality, and healthcare utilization in a national cohort of Veterans with cirrhosis.
    Hepatology. 2019 May 20. doi: 10.1002/hep.30779.
    >> Share

  589. HOOGERLAND JA, Lei Y, Wolters JC, de Boer JF, et al
    Glucose-6-phosphate regulates hepatic bile acid synthesis in mice.
    Hepatology. 2019 May 18. doi: 10.1002/hep.30778.
    >> Share

  590. WANG P, Wang WJ, Choi-Nurvitadhi J, Lescaille Y, et al
    Rat OATP1A1 Interacts Directly With OATP1A4 Facilitating Its Maturation and Trafficking to the Hepatocyte Plasma Membrane.
    Hepatology. 2019 May 18. doi: 10.1002/hep.30772.
    >> Share

  591. SIEW SM, Cunningham SC, Zhu E, Tay SS, et al
    Prevention of cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV-piggyBac gene therapy.
    Hepatology. 2019 May 17. doi: 10.1002/hep.30773.
    >> Share

  592. PERRET C, Decaens T
    mTOR inhibitors, new drugs for CTNNB1-mutated hepatocellular carcinomas?
    Hepatology. 2019 May 16. doi: 10.1002/hep.30768.
    >> Share

  593. JIANG N, Li X, Xing YF, Qiao YD, et al
    Local regional therapy before liver transplantation for hepatocellular carcinoma.
    Hepatology. 2019 May 15. doi: 10.1002/hep.30769.
    >> Share

  594. GLUCHOWSKI NL, Gabriel KR, Chitraju C, Bronson RT, et al
    Hepatocyte Deletion of Triglyceride-Synthesis Enzyme DGAT2 Reduces Steatosis without Increasing Inflammation or Fibrosis.
    Hepatology. 2019 May 13. doi: 10.1002/hep.30765.
    >> Share

  595. CHOUDHARY NS, Saigal S, Saraf N, Soin AS, et al
    Prognostic role of ammonia in cirrhotic patients.
    Hepatology. 2019 May 11. doi: 10.1002/hep.30758.
    >> Share

  596. YAN ZZ, Huang YP, Wang X, Wang HP, et al
    Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia-Reperfusion Injury in Mice.
    Hepatology. 2019 May 11. doi: 10.1002/hep.30705.
    >> Share

  597. OGESE MO, Jenkins RE, Adair K, Tailor A, et al
    Exosomal transport of hepatocyte-derived drug-modified proteins to the immune system.
    Hepatology. 2019 May 9. doi: 10.1002/hep.30701.
    >> Share

  598. NA S, Wang H, Bank T, Perera A, et al
    FAK and beta-Catenin Cooperate to Induce Hepatocellular Carcinoma.
    Hepatology. 2019 May 9. doi: 10.1002/hep.30707.
    >> Share

  599. MA F, Zhu Y, Liu X, Zhou Q, et al
    Dyrk3 loss activates the purine metabolism and promotes hepatocellular carcinoma progression.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30703.
    >> Share

  600. TAPPER EB, Hao S, Lin M, Mafi JN, et al
    The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30695.
    >> Share

  601. XU Z, Xu M, Liu P, Zhang S, et al
    The mTORC2-Akt cascade is crucial for c-Myc to promote hepatocarcinogenesis in mice and men.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30697.
    >> Share

  602. XIAO Y, Liu R, Li X, Gurley EC, et al
    Long non-coding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30698.
    >> Share

  603. TRIVEDI HD, Lau DTY, Kulai TB, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1849-1851.
    >> Share

    April 2019
  604. NARDELLI S, Lattanzi B, Merli M, Farcomeni A, et al
    Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis.
    Hepatology. 2019 Apr 30. doi: 10.1002/hep.30692.
    >> Share

  605. BAJAJ JS, Salzman NH, Acharya C, Sterling RK, et al
    Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Hepatology. 2019 Apr 30. doi: 10.1002/hep.30690.
    >> Share

  606. ALISON MR, Lin WR
    Periportal Sox9-positive hepatocytes: progenitors with a biliary leaning.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30687.
    >> Share

  607. BHANJI RA, Montano-Loza AJ, Watt KD
    SARCOPENIA IN CIRRHOSIS: Looking beyond the skeletal muscle loss to see the systemic disease.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30686.
    >> Share

  608. CHEUNG A, Neuschwander-Tetri BA, Kleiner DE, Schabel E, et al
    Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30672.
    >> Share

  609. BADAWY AA
    The Kynurenine Pathway in Hepatic Cirrhosis.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30680.
    >> Share

  610. STARLINGER P, Pereyra D, Hackl M, Assinger A, et al
    miRNA Signatures in Cirrhotic Patients.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30682.
    >> Share

  611. LI YM, Liu ZY, Wang JC, Yu JM, et al
    RIP3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the CXCL1-CXCR2 axis.
    Hepatology. 2019 Apr 25. doi: 10.1002/hep.30676.
    >> Share

  612. DEROSSI C, Bambino K, Morrison J, Sakarin I, et al
    Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans.
    Hepatology. 2019 Apr 23. doi: 10.1002/hep.30677.
    >> Share

  613. XIE Y, Matsumoto H, Kennedy S, Newberry EP, et al
    Impaired chylomicron assembly modifies hepatic metabolism through bile acid dependent and transmissible microbial adaptations.
    Hepatology. 2019 Apr 20. doi: 10.1002/hep.30669.
    >> Share

  614. WANG Y, Tu K, Liu D, Guo L, et al
    P300 Acetyltransferase is a Cytoplasm-to-Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in TGFbeta-stimulated Hepatic Stellate Cells.
    Hepatology. 2019 Apr 20. doi: 10.1002/hep.30668.
    >> Share

  615. STOTTS MJ, Adjapong O, Kaplan DE
    A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: a Case Report.
    Hepatology. 2019 Apr 20. doi: 10.1002/hep.30659.
    >> Share

  616. LI Q, Pan X, Zhu D, Deng Z, et al
    Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma via the miR-338-3p/PKM2 axis under hypoxic stress.
    Hepatology. 2019 Apr 20. doi: 10.1002/hep.30671.
    >> Share

  617. HAGE C, Hoves S, Strauss L, Bissinger S, et al
    Sorafenib Induces Pyroptosis in Macrophages and Triggers NK Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30666.
    >> Share

  618. LEVITSKY J, Asrani SK, Abecassis M, Ruiz R, et al
    External Validation of a Pre-Transplant Biomarker Model (REVERSE) Predictive of Renal Recovery after Liver Transplantation.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30667.
    >> Share

  619. SANYAL AJ, Harrison SA, Ratziu V, Abdelmalek MF, et al
    The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30664.
    >> Share

  620. YANG HD, Kim HS, Kim SY, Na MJ, et al
    HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-mediated Anti-tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30657.
    >> Share

  621. DO A, Kuszewski EJ, Mehal WZ
    Incorporating Weight Loss Medications into Hepatology Practice for Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Apr 16. doi: 10.1002/hep.30658.
    >> Share

  622. LIU R, Li X, Zhu W, Wang Y, et al
    Cholangiocyte-derived exosomal LncRNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.
    Hepatology. 2019 Apr 15. doi: 10.1002/hep.30662.
    >> Share

  623. HE Y, Hwang S, Cai Y, Kim SJ, et al
    MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30645.
    >> Share

  624. DESROCHES-CASTAN A, Tillet E, Ricard N, Ouarne M, et al
    BMP9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting from hepatic fibrosis.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30655.
    >> Share

  625. LI N, Wei L, Liu X, Bai H, et al
    A frizzled-like cysteine rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30646.
    >> Share

  626. CHEN YJ, Tsai CF, Wang YP, Lu CL, et al
    To the editor: Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30641.
    >> Share

  627. DHANASEKARAN R, Felsher DW
    A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC).
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30649.
    >> Share

  628. VUPPALANCHI R, Chalasani N
    HEP-18-0797.R2 - Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension - The Devil is In the Details.
    Hepatology. 2019 Apr 5. doi: 10.1002/hep.30640.
    >> Share

  629. MOON AM, Hayashi PH, Barritt AS 4th
    Proton pump inhibitors in cirrhosis: a marker of morbid conditions or cause of mortality.
    Hepatology. 2019 Apr 5. doi: 10.1002/hep.30642.
    >> Share

  630. NARDELLI S, Gioia S, Ridola L, Farcomeni A, et al
    PPIs in cirrhosis: more evidences for a careful prescription!
    Hepatology. 2019 Apr 4. doi: 10.1002/hep.30639.
    >> Share

  631. NAIR KM, Vora RS, Mousa OY, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1365-1368.
    >> Share

  632. ZHOU SL, Yin D, Hu ZQ, Luo CB, et al
    A Positive Feedback Loop between Cancer Stem-Like Cells and Tumor- Associated Neutrophils Controls Hepatocellular Carcinoma Progression.
    Hepatology. 2019 Apr 1. doi: 10.1002/hep.30630.
    >> Share

    March 2019
  633. BROWN ZJ, Greten TF, Heinrich B
    Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy.
    Hepatology. 2019 Mar 30. doi: 10.1002/hep.30633.
    >> Share

  634. KAO WY, Tan EC, Su CW
    Reply to comment: Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma.
    Hepatology. 2019 Mar 30. doi: 10.1002/hep.30632.
    >> Share

  635. ELKRIEF L, Ferrusquia-Acosta J, Payance A, Moga L, et al
    Abdominal surgery in patients with idiopathic noncirrhotic portal hypertension: a multicenter retrospective study.
    Hepatology. 2019 Mar 29. doi: 10.1002/hep.30628.
    >> Share

  636. RUSSELL BE, Whaley KG, Bove KE, Labilloy A, et al
    Expanding and Underscoring the Hepato-Encephalopathic Phenotype of QIL1/MIC13.
    Hepatology. 2019 Mar 26. doi: 10.1002/hep.30627.
    >> Share

  637. YANG J, Trepo E, Nahon P, Cao Q, et al
    A HSD17B13 variant protects from hepatocellular carcinoma development in alcoholic liver disease.
    Hepatology. 2019 Mar 25. doi: 10.1002/hep.30623.
    >> Share

  638. WANG YL, Liu JY, Yang JE, Yu XM, et al
    Lnc-UCID promotes G1/S transition and hepatoma growth by preventing DHX9-mediated CDK6 downregulation.
    Hepatology. 2019 Mar 13. doi: 10.1002/hep.30613.
    >> Share

  639. WANG C, Zheng X, Jiang P, Tang R, et al
    Genome Wide Association Studies of Specific Antinuclear Autoantibody Sub-phenotypes in Primary Biliary Cholangitis.
    Hepatology. 2019 Mar 10. doi: 10.1002/hep.30604.
    >> Share

  640. MA M, Xu H, Liu G, Wu J, et al
    MITA1, a novel energy stress-inducible lncRNA, promotes hepatocellular carcinoma metastasis.
    Hepatology. 2019 Mar 6. doi: 10.1002/hep.30602.
    >> Share

  641. HUANG Z, Wu LM, Zhang JL, Sabri A, et al
    DUSP12 Regulates Hepatic Lipid Metabolism through Inhibition of Lipogenesis and ASK1 Pathways.
    Hepatology. 2019 Mar 1. doi: 10.1002/hep.30597.
    >> Share

  642. MOUSA O, Malhi H, Schwartz RE, Kulai TB, et al
    Hepatology Highlights.
    Hepatology. 2019;69:927-930.
    >> Share

    February 2019
  643. HUELIN P, Sola E, Elia C, Sole C, et al
    Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis. A prospective study.
    Hepatology. 2019 Feb 27. doi: 10.1002/hep.30592.
    >> Share

  644. HARA K, Takeda A, Tsurugai Y, Saigusa Y, et al
    Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: a Propensity Score Analysis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30591.
    >> Share

  645. HARRISON SA, Rossi SJ, Paredes AH, Trotter JF, et al
    NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30590.
    >> Share

  646. WANG Y, Kory N, Cohen JC, Hobbs HH, et al
    PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30583.
    >> Share

  647. TODESCA P, Marzi L, Critelli RM, Cuffari B, et al
    Angiopoietin-2/Tie2 inhibition by regorafenib associates with striking response in a patient with aggressive hepatocellular carcinoma.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30588.
    >> Share

  648. RIMBAS RC, Rimbas M, Vinereanu D
    Echocardiographic Predictors of a Worse Outcome in Patients With Liver Cirrhosis: What Should We Assess?
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30584.
    >> Share

  649. WANG R, Zhu P
    Tuberculosis and anti-tuberculosis treatments cannot be ignored when evaluating cirrhotic patients co-infected with HIV or not.
    Hepatology. 2019 Feb 25. doi: 10.1002/hep.30582.
    >> Share

  650. KAPURIA D, Ben-Yakov G, Ortolano R, Ho-Cho M, et al
    The Spectrum of Hepatic Involvement in Patients with Telomere Disease.
    Hepatology. 2019 Feb 21. doi: 10.1002/hep.30578.
    >> Share

  651. MEHAL WZ, Loomba R
    The Intestinal Microbiome, Plasma Metabolome and Liver Transcriptome- A Conspiracy Driving Hepatic Steatosis.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30577.
    >> Share

  652. SINHA J, Mehta N, Dodge JL, Poltavskiy E, et al
    Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30570.
    >> Share

  653. WEN W, Schwabe RF
    Soluble fibers improve metabolic syndrome but may cause liver disease and hepatocellular carcinoma.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30565.
    >> Share

  654. NGUYEN MH
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30560.
    >> Share

  655. LAI SW, Lin CL
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30566.
    >> Share

  656. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    >> Share

  657. TONG J, Han CJ, Zhang JZ, He WZ, et al
    Hepatic IRF6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing PPARgamma.
    Hepatology. 2019 Feb 12. doi: 10.1002/hep.30559.
    >> Share

  658. QIAO Y, Wang J, Karagoz E, Liang B, et al
    Axin1 deletion induced hepatocarcinogenesis requires intact beta-Catenin but not Notch cascade in mice.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30556.
    >> Share

  659. DEY P
    Carbon Tetrachloride (CCl4 )-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30555.
    >> Share

  660. ALBILLOS A, Munoz L, Alvarez-Mon M
    Reply to: Carbon Tetrachloride (CCl4)-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30554.
    >> Share

  661. TSANG FH, Law CT, Tang CT, Cheng CL, et al
    Aberrant super-enhancer landscape in human hepatocellular carcinoma.
    Hepatology. 2019 Feb 5. doi: 10.1002/hep.30544.
    >> Share

  662. MWANGI SM, Li G, Ye L, Liu Y, et al
    Glial Cell Line Derived Neurotrophic Factor Enhances Autophagic Flux in Mouse and Rat Hepatocytes and Protects Against Palmitate Lipotoxicity.
    Hepatology. 2019 Feb 4. doi: 10.1002/hep.30541.
    >> Share

  663. RUSSO N, Brown RS Jr, Shah SL, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2019;69:469-472.
    >> Share

    January 2019
  664. SHALIMAR, Sheikh MF, Mookerjee RP, Agarwal B, et al
    Prognostic Role of Ammonia in Cirrhotic Patients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30534.
    >> Share

  665. TAPPER EB
    Predicting Overt Hepatic Encephalopathy for the Population with Cirrhosis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30533.
    >> Share

  666. BAI L, Chen MM, Chen ZD, Zhang P, et al
    FBXW5 mediates the ubiquitination of ASK1 and exacerbates nonalcoholic steatohepatitis.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30537.
    >> Share

  667. KIM D, Brocker CN, Takahashi S, Yagai T, et al
    Keratin 23 is a PPARA-dependent, MYC-amplified oncogene that promotes hepatocyte proliferation.
    Hepatology. 2019 Jan 29. doi: 10.1002/hep.30530.
    >> Share

  668. ZEUZEM S, Bourgeois S, Greenbloom S, Buti M, et al
    JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-infected Patients without Cirrhosis: OMEGA-1.
    Hepatology. 2019 Jan 28. doi: 10.1002/hep.30527.
    >> Share

  669. PORTA C, Broglia C, Negri F
    Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30521.
    >> Share

  670. WONG GL, Liang LY, Kwok R, Hui AJ, et al
    Low risk of variceal bleeding in cirrhotic patients after variceal screening stratified by liver/spleen stiffness.
    Hepatology. 2019 Jan 25. doi: 10.1002/hep.30522.
    >> Share

  671. YE X, Li C, Zu X, Lin M, et al
    A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30519.
    >> Share

  672. PRATT DS
    Hepatology Elsewhere.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30517.
    >> Share

  673. HASAN KM, Friedman TC, Shao X, Parveen M, et al
    E-cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases.
    Hepatology. 2019 Jan 21. doi: 10.1002/hep.30512.
    >> Share

  674. CAI J, Zhang XJ, Li H
    The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30506.
    >> Share

  675. ZHENG Y, Qu H, Xiong X, Wang Y, et al
    Deficiency of the mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis.
    Hepatology. 2019 Jan 17. doi: 10.1002/hep.30507.
    >> Share

  676. CHEN H, Gao F, He M, Ding XF, et al
    Long-read RNA Sequencing identifies Novel Splice Variants in Hepatocellular Carcinoma and Tumor-specific Isoforms.
    Hepatology. 2019 Jan 13. doi: 10.1002/hep.30500.
    >> Share

  677. MAHMUD N, Kaplan DE, Taddei TH, Goldberg DS, et al
    Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30494.
    >> Share

  678. GOEPPERT B, Toth R, Singer S, Albrecht T, et al
    Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30493.
    >> Share

  679. HEERKENS M, Dedden S, Scheepers H, Van Paassen P, et al
    Effect of plasmapheresis on cholestatic pruritus and autotaxin activity during pregnancy.
    Hepatology. 2019 Jan 7. doi: 10.1002/hep.30496.
    >> Share

  680. RUSSO N, Jesudian A, Shen NT, Brown RS Jr, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1-4.
    >> Share

    December 2018
  681. KANWAL F, Tapper EB, Ho C, Asrani SK, et al
    Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30489.
    >> Share

  682. SHIFFMAN ML, Sussman NL, Ravendhran N, Ditmyer M, et al
    Financial compensation for hepatologists in different practice settings.
    Hepatology. 2018 Dec 26. doi: 10.1002/hep.30488.
    >> Share

  683. MOORE A, Wu L, Chuang JC, Sun X, et al
    Arid1a loss drives non-alcoholic steatohepatitis in mice via epigenetic dysregulation of hepatic lipogenesis and fatty acid oxidation.
    Hepatology. 2018 Dec 25. doi: 10.1002/hep.30487.
    >> Share

  684. HUYNH H, Lee LY, Goh KY, Ong R, et al
    Infigratinib mediates vascular normalization, impairs metastasis and improves chemotherapy in hepatocellular carcinoma.
    Hepatology. 2018 Dec 21. doi: 10.1002/hep.30481.
    >> Share

  685. COTTER TG, Charlton M
    The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality from Cirrhosis.
    Hepatology. 2018 Dec 20. doi: 10.1002/hep.30408.
    >> Share

  686. SALMON-CERON D, Nahon P, Layese R, Bourcier V, et al
    HIV/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients.
    Hepatology. 2018 Dec 19. doi: 10.1002/hep.30400.
    >> Share

  687. CHEHADE S, Adams PC
    Severe hemochromatosis arthropathy in the absence of iron overload.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30469.
    >> Share

  688. LEE D, Xu IM, Chiu DK, Leibold J, et al
    Induction of Oxidative Stress via Inhibition of Thioredoxin Reductase 1 is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30467.
    >> Share

  689. RIVEIRO-BARCIELA M, Gironella M, Senin A, Salcedo MT, et al
    Decompensated liver disease due to primary hepatic amyloidosis: Is liver transplantation still mandatory?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30464.
    >> Share

  690. ZUO X, Chen Z, Cai J, Gao W, et al
    5-hydroxytryptamine receptor 1D aggravates hepatocellular carcinoma progression via FoxO6 in AKT-dependent and independent manners.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30430.
    >> Share

  691. FUNKE K, Rockey DC
    Cholestatic drug induced liver injury caused by mifepristone.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30465.
    >> Share

  692. YANG JD, Patel T
    Early Detection of Hepatocellular Carcinoma - Expanding the Utility of Circulating Tumor Markers.
    Hepatology. 2018 Dec 17. doi: 10.1002/hep.30468.
    >> Share

  693. UNZU C, Planet E, Brandenberg N, Fusil F, et al
    Pharmacological induction of a progenitor state for the efficient expansion of primary human hepatocytes.
    Hepatology. 2018 Dec 14. doi: 10.1002/hep.30425.
    >> Share

  694. MEHTA N, Dodge JL, Roberts JP, Hirose R, et al
    Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes.
    Hepatology. 2018 Dec 13. doi: 10.1002/hep.30413.
    >> Share

  695. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    >> Share

  696. CLARIA J, Moreau R, Fenaille F, Amoros A, et al
    Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis.
    Hepatology. 2018 Dec 6. doi: 10.1002/hep.30363.
    >> Share

  697. HUANG L, Cai J, Guo H, Gu J, et al
    ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30404.
    >> Share

  698. MO DC, Jia RR, Zhong JH
    Hepatic Resection Compared to Chemoembolization in Intermediate to Advanced-Stage HCC: a comment for moving forward.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30409.
    >> Share

  699. BALE R, Schullian P, Eberle G, Putzer D, et al
    Stereotactic radiofrequency ablation of hepatocellular carcinoma - A histopathological study in explanted livers.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30406.
    >> Share

  700. HUCK I, Gunewardena S, Espanol-Suner R, Willenbring H, et al
    Hepatocyte Nuclear Factor 4 alpha (HNF4alpha) Activation is Essential for Termination of Liver Regeneration.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30405.
    >> Share

  701. KHAMBU B, Li T, Yan S, Yu C, et al
    Hepatic Autophagy Deficiency Compromises FXR Functionality and Causes Cholestatic Injury.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30407.
    >> Share

  702. SIMONETTO DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, et al
    Management of Sepsis in Patients with Cirrhosis: current evidence and practical approach.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30412.
    >> Share

  703. LAW CT, Wei L, Tsang FH, Chan CY, et al
    HELLS regulates chromatin remodeling and epigenetic silencing of multiple tumor suppressor genes in human hepatocellular carcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30414.
    >> Share

  704. ALVES-BEZERRA M, Li Y, Acuna M, Ivanova AA, et al
    Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids into Triglyceride Biosynthesis.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30411.
    >> Share


  705. 2018 HEPATOLOGY Referees (Volumes 67 and 68).
    Hepatology. 2018;68:2446-2452.
    >> Share

  706. SHEN NT, Brown RS Jr, Imai N, Krisko TI, et al
    Hepatology Highlights.
    Hepatology. 2018;68:2049-2052.
    >> Share

  707. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    >> Share

  708. GIOIA S, Nardelli S, Riggio O
    Liver stiffness in non-cirrhotic portal hypertension - The Devil is in the diagnosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30367.
    >> Share

  709. FANG JH, Xu L, Shang LR, Pan CZ, et al
    Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30366.
    >> Share

  710. MA Y, Yang W, Simon TG, Smith-Warner SA, et al
    Dietary patterns and risk of hepatocellular carcinoma among US men and women.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30362.
    >> Share

  711. ARORA V, Sarin SK
    Reply.
    Hepatology. 2018;68:2444.
    >> Share

  712. VERMA S, Agarwal S, Singh S, Pandey N, et al
    Letter To Editor: Terlipressin is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute On Chronic Liver Failure.
    Hepatology. 2018;68:2442-2443.
    >> Share

  713. IMAI N, Cohen DE
    Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD.
    Hepatology. 2018;68:2062-2065.
    >> Share

  714. BRENNER DA
    Of Mice and Men and Nonalcoholic Steatohepatitis.
    Hepatology. 2018;68:2059-2061.
    >> Share

  715. KHADERI S, Sussman N, Kanwal F
    Project ECHO: The Specialist Will See You Now.
    Hepatology. 2018;68:2066-2068.
    >> Share

  716. MIN JH, Kim JM, Kim YK, Kang TW, et al
    Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System.
    Hepatology. 2018;68:2254-2266.
    >> Share

  717. LOPICCOLO J, Brener MI, Oshima K, Lipson EJ, et al
    Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade.
    Hepatology. 2018;68:2431-2433.
    >> Share

  718. CALVOPINA DA, Chatfield MD, Weis A, Coleman MA, et al
    MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Hepatology. 2018;68:2301-2316.
    >> Share

  719. ALLEN AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, et al
    Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database.
    Hepatology. 2018;68:2230-2238.
    >> Share

  720. GE X, Arriazu E, Magdaleno F, Antoine DJ, et al
    High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
    Hepatology. 2018;68:2380-2404.
    >> Share

  721. SU GL, Glass L, Tapper EB, Van T, et al
    Virtual Consultations Through the Veterans Administration SCAN-ECHO Project Improves Survival for Veterans With Liver Disease.
    Hepatology. 2018;68:2317-2324.
    >> Share

  722. XU X, Krumm C, So JS, Bare CJ, et al
    Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction.
    Hepatology. 2018;68:2167-2181.
    >> Share

  723. GONG S, Yan Z, Liu Z, Niu M, et al
    Intestinal microbiota mediates the susceptibility to polymicrobial sepsis-induced liver injury by granisetron generation in mice.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30361.
    >> Share

    November 2018
  724. NEONG SF, Billington EO, Congly SE
    Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management.
    Hepatology. 2018 Nov 23. doi: 10.1002/hep.30359.
    >> Share

  725. MA Y, Belyaeva OV, Brown PM, Fujita K, et al
    HSD17B13 is a Hepatic Retinol Dehydrogenase Associated with Histological Features of Non-Alcoholic Fatty Liver Disease.
    Hepatology. 2018 Nov 11. doi: 10.1002/hep.30350.
    >> Share

  726. MUNOZ L, Borrero MJ, Ubeda M, Conde E, et al
    Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis.
    Hepatology. 2018 Nov 10. doi: 10.1002/hep.30349.
    >> Share

  727. SUN H, Huang Q, Huang M, Wen H, et al
    Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma.
    Hepatology. 2018 Nov 8. doi: 10.1002/hep.30347.
    >> Share

  728. SANTAMARIA E, Rodriguez-Ortigosa CM, Uriarte I, Latasa MU, et al
    The epidermal growth factor receptor ligand amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis.
    Hepatology. 2018 Nov 8. doi: 10.1002/hep.30348.
    >> Share

  729. SHAHEEN AA, Swain MG
    Using proper methods to identify cirrhosis patients in administrative databases is crucial to correctly predict outcomes.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30343.
    >> Share

  730. LABGAA I, Demartines N, Melloul E
    Surgical Resection vs. Transarterial Chemoembolization for Intermediate Stage Hepatocellular Carcinoma (BCLC-B): An Unsolved Question.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30338.
    >> Share

  731. TAPPER EB, Baki J, Parikh ND, Lok AS, et al
    Frailty, Psychoactive Medications, and Cognitive Dysfunction are Associated with Poor Patient-Reported Outcomes in Cirrhosis.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30336.
    >> Share

  732. WANG YH, Chuang YH, Wu CF, Jan MC, et al
    Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30339.
    >> Share

  733. FLYNN MJ, Sayed AA, Sharma R, Siddique A, et al
    Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinoma.
    Hepatology. 2018 Nov 1. doi: 10.1002/hep.30337.
    >> Share


  734. Hepatology Highlights.
    Hepatology. 2018;68:1665-1667.
    >> Share

  735. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:2046-2048.
    >> Share

  736. CARDOSO FS
    Acute-on-Chronic Liver Failure defined by NACSELD: The Impact on Prognosis and Futility of Care.
    Hepatology. 2018;68:2046.
    >> Share

  737. MUZYKANTOV VR, Brenner JS
    Vascular Immunotargeting: Take the Highway to the First Exit.
    Hepatology. 2018;68:1672-1674.
    >> Share

  738. TARGHER G, Byrne CD
    Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?
    Hepatology. 2018;68:1668-1671.
    >> Share

  739. KORATALA A, Alquadan KF
    Diminishing Kidney Reserve and the "Pseudo"normal Creatinine.
    Hepatology. 2018;68:2045.
    >> Share

  740. NOH JH, Gorospe M
    AKTions by Cytoplasmic lncRNA CASC9 Promote Hepatocellular Carcinoma Survival.
    Hepatology. 2018;68:1675-1677.
    >> Share

  741. TUFONI M, Serena Ricci C, Zaccherini G
    A Case of Immune-Mediated Liver Injury Induced by Olaparib.
    Hepatology. 2018;68:2039-2041.
    >> Share

  742. KLINGENBERG M, Gross M, Goyal A, Polycarpou-Schwarz M, et al
    The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling.
    Hepatology. 2018;68:1817-1832.
    >> Share

  743. WU R, Murali R, Kabe Y, French SW, et al
    Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition.
    Hepatology. 2018;68:1726-1740.
    >> Share

  744. YU CJ, Wang QS, Wu MM, Song BL, et al
    TRUSS Exacerbates NAFLD Development by Promoting IkappaBalpha Degradation in Mice.
    Hepatology. 2018;68:1769-1785.
    >> Share

  745. KIM G, Lee SE, Lee YB, Jun JE, et al
    Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Hepatology. 2018;68:1755-1768.
    >> Share

    October 2018
  746. VITALE A, Farinati F, Borzio M, Trevisani F, et al
    The critical issue of restaging patients with hepatocellular carcinoma.
    Hepatology. 2018 Oct 30. doi: 10.1002/hep.30322.
    >> Share

  747. FARRELL G, Schattenberg JM, Leclercq I, Yeh MM, et al
    Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30333.
    >> Share

  748. ASLAM A, Ishtiaq R, Lau DTY
    Commentary for Hepatology Elsewhere Timely administration of birth dose HBV vaccine may break the chain of perinatal transmission.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30332.
    >> Share

  749. CASTRO NARRO GE, Gamboa Dominguez A, Consuelo Sanchez A, Salazar Martinez A, et al
    Combined Hepatocellular-Cholangiocarcinoma in a Patient with Cirrhosis due to Cholesteryl Ester Storage Disease.
    Hepatology. 2018 Oct 29. doi: 10.1002/hep.30331.
    >> Share

  750. KIM HL, An J, Park JA, Park SH, et al
    Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High Risk Patients with Cirrhosis.
    Hepatology. 2018 Oct 26. doi: 10.1002/hep.30330.
    >> Share

  751. FU Y, Urban DJ, Nani RR, Zhang YF, et al
    Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma.
    Hepatology. 2018 Oct 24. doi: 10.1002/hep.30326.
    >> Share

  752. HUO TI, Liu PH, Hsu CY
    Staging and restaging for hepatocellular carcinoma: Solution of confusion?
    Hepatology. 2018 Oct 24. doi: 10.1002/hep.30324.
    >> Share

  753. YAN J, Yao B, Kuang H, Yang X, et al
    Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD.
    Hepatology. 2018 Oct 19. doi: 10.1002/hep.30320.
    >> Share

  754. CHEN Y, Hao X, Sun R, Wei H, et al
    NK cell-derived IFN-gamma promotes hepatocellular carcinoma through EpCAM-EMT axis in hepatitis B virus transgenic mice.
    Hepatology. 2018 Oct 17. doi: 10.1002/hep.30317.
    >> Share

  755. BANALES JM, Inarrairaegui M, Arbelaiz A, Milkiewicz P, et al
    Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis.
    Hepatology. 2018 Oct 16. doi: 10.1002/hep.30319.
    >> Share

  756. VENTURA-COTS M, Watts AE, Cruz-Lemini M, Shah ND, et al
    Colder weather and fewer sunlight hours increase alcohol consumption and alcoholic cirrhosis worldwide.
    Hepatology. 2018 Oct 16. doi: 10.1002/hep.30315.
    >> Share

  757. ABRALDES JG, Trebicka J, Chalasani N, D'Amico G, et al
    Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.
    Hepatology. 2018 Oct 15. doi: 10.1002/hep.30314.
    >> Share

  758. KO E, Seo HW, Jung ES, Ju S, et al
    PI3Kdelta is a new therapeutic target in hepatocellular carcinoma.
    Hepatology. 2018 Oct 9. doi: 10.1002/hep.30307.
    >> Share

  759. PERUGORRIA MJ, Olaizola P, Banales JM
    Cholangiocyte-to-Hepatocyte Differentiation: a Context Dependent Process and an Opportunity for Regenerative Medicine.
    Hepatology. 2018 Oct 8. doi: 10.1002/hep.30305.
    >> Share

  760. NARDELLI S, Gioia S, Ridola L, Farcomeni A, et al
    Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30304.
    >> Share

  761. LAI SW
    Proton pump inhibitors use and risk of hepatocellular carcinoma.
    Hepatology. 2018 Oct 5. doi: 10.1002/hep.30302.
    >> Share

  762. BLANER WS
    Hepatic Stellate Cells (HSCs) and Retinoids: Towards A Much More Defined Relationship.
    Hepatology. 2018 Oct 4. doi: 10.1002/hep.30293.
    >> Share

  763. ZHANG T, Duan J, Zhang L, Li Z, et al
    LXRalpha Promotes Hepatosteatosis in Part via Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1beta Expression.
    Hepatology. 2018 Oct 3. doi: 10.1002/hep.30301.
    >> Share


  764. Hepatology Highlights.
    Hepatology. 2018;68:1213-1216.
    >> Share

  765. CHEN JF, Lin BL
    Reply.
    Hepatology. 2018;68:1661.
    >> Share

  766. YANG Y, Feng Y, Zhao X, Wang L, et al
    A New Concept: Pre-HCC Disease.
    Hepatology. 2018;68:1662.
    >> Share

  767. PANDEY S
    Association of Nonalcoholic Fatty Liver Disease With Relative Skeletal Muscle Mass: A Public Health Perspective.
    Hepatology. 2018;68:1657.
    >> Share

  768. BAJAJ JS, Moreau R, Kamath PS, Vargas HE, et al
    Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
    Hepatology. 2018;68:1621-1632.
    >> Share

  769. TRICO D, Caprio S, Rosaria Umano G, Pierpont B, et al
    Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.
    Hepatology. 2018;68:1376-1390.
    >> Share

  770. GRAHAM RP, Lackner C, Terracciano L, Gonzalez-Cantu Y, et al
    Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
    Hepatology. 2018;68:1441-1447.
    >> Share

  771. SALEM R, Gabr A, Riaz A, Mora R, et al
    Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
    Hepatology. 2018;68:1429-1440.
    >> Share

    September 2018
  772. SIRICA AE, Gores GJ, Groopman JD, Selaru FM, et al
    Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
    Hepatology. 2018 Sep 25. doi: 10.1002/hep.30289.
    >> Share

  773. WILKINSON PD, Delgado ER, Alencastro F, Leek MP, et al
    The polyploid state restricts hepatocyte proliferation and liver regeneration.
    Hepatology. 2018 Sep 23. doi: 10.1002/hep.30286.
    >> Share

  774. COSTENTIN CE, Bababekov YJ, Zhu AX, Yeh H, et al
    Is it time to reconsider the Milan Criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30278.
    >> Share

  775. SATSANGI S
    Noradrenaline for hepatorenal syndrome in patients with acute-on chronic liver failure- Hope still remains!
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30283.
    >> Share

  776. VOLK M, Mellinger J, Bansal MB, Gellad ZF, et al
    A Roadmap for Value-Based Payment Models among Patients with Cirrhosis.
    Hepatology. 2018 Sep 18. doi: 10.1002/hep.30277.
    >> Share

  777. MUMTAZ K, Issak A, Porter K, Kelly S, et al
    Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic patients: A Model Based on the Administrative Database.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30274.
    >> Share

  778. SONG ATW, Abdala E, de Martino RB, Malbouisson LMS, et al
    Liver transplantation for fulminant hepatitis due to yellow fever.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30273.
    >> Share

  779. RUSSELL JO, Lu WY, Okabe H, Abrams M, et al
    Hepatocyte-specific beta-catenin deletion during severe liver injury provokes cholangiocytes to differentiate into hepatocytes.
    Hepatology. 2018 Sep 14. doi: 10.1002/hep.30270.
    >> Share

  780. RAEVENS S, Colle I
    Why pulse oximetry is inaccurate in liver cirrhosis - ancient knowledge.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30260.
    >> Share

  781. CAMPANI C, Guido M, Colagrande S, Bartoli F, et al
    A large rheumatoid nodule mimicking hepatic malignancy.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30261.
    >> Share

  782. YOUNOSSI ZM, Tampi R, Priyadarshini M, Nader F, et al
    Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30254.
    >> Share

  783. INZAUGARAT ME, Johnson CD, Holtmann TM, McGeough MD, et al
    NLRP3 inflammasome activation in hepatic stellate cells induces murine liver fibrosis.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30252.
    >> Share

  784. YOUNOSSI Z, Tacke F, Arrese M, Sharma BC, et al
    Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30251.
    >> Share

  785. KAMATH B, Mack CL
    From hepatocyte to cholangiocyte: the remarkable potential of transdifferentiation to treat cholestatic diseases.
    Hepatology. 2018 Sep 4. doi: 10.1002/hep.30250.
    >> Share

  786. KAO WY, Su CW, Tan EC, Lee PC, et al
    Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B or C.
    Hepatology. 2018 Sep 2. doi: 10.1002/hep.30247.
    >> Share

  787. BROWN RS JR, Schwartz RE
    Hepatology Highlights.
    Hepatology. 2018;68:795-797.
    >> Share

  788. LO GH
    The Use of Steroid for Transcatheter Arterial Chemoembolization: To Relieve Symptoms or to Mask Adverse Events?
    Hepatology. 2018;68:1207.
    >> Share

  789. FUJIWARA K, Yasui S, Yokosuka O, Oda S, et al
    A Role of Renal Replacement Therapy for Acute Liver Failure.
    Hepatology. 2018;68:1204.
    >> Share

  790. CUMMINGS D, Ferstenberg R
    Recommendations for the Evaluation for Autoimmune Liver Disease in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2018;68:1203.
    >> Share

  791. LEWIS K, Takebe T
    Tumoroid a la carte: Path for personalization.
    Hepatology. 2018;68:1189-1191.
    >> Share

  792. DENISOV EV, Perelmuter VM
    A fixed partial epithelial-mesenchymal transition (EMT) triggers carcinogenesis, whereas asymmetrical division of hybrid EMT cells drives cancer progression.
    Hepatology. 2018;68:807-810.
    >> Share

  793. MATAK A, Lahiri P, Ford E, Pabst D, et al
    Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
    Hepatology. 2018;68:933-948.
    >> Share

  794. RANDALL MH, Stoermann M, Rockey DC
    A "Faux" Case of Acute Liver Failure in a 28-Year-Old Pregnant Woman.
    Hepatology. 2018;68:1200-1202.
    >> Share

  795. YANG E, Peng L, Lee WM
    Multiple admissions for acetaminophen overdose: Acetaminophen frequent fliers, a new entity?
    Hepatology. 2018;68:1197-1199.
    >> Share

  796. CHAPIN CA, Burn T, Meijome T, Loomes KM, et al
    Indeterminate pediatric acute liver failure is uniquely characterized by a CD103(+) CD8(+) T-cell infiltrate.
    Hepatology. 2018;68:1087-1100.
    >> Share

  797. LAN T, Li C, Yang G, Sun Y, et al
    Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.
    Hepatology. 2018;68:1070-1086.
    >> Share

    August 2018
  798. KISIEL JB, Dukek BA, Kanipakam RVSR, Ghoz HM, et al
    Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation.
    Hepatology. 2018 Aug 31. doi: 10.1002/hep.30244.
    >> Share

  799. MOTINO O, Frances DE, Casanova N, Fuertes-Agudo M, et al
    Protective role of hepatocyte cyclooxygenase-2 expression against liver ischemia-reperfusion injury in mice.
    Hepatology. 2018 Aug 29. doi: 10.1002/hep.30241.
    >> Share

  800. CHOI J, Kim GA, Han S, Lee W, et al
    Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 28. doi: 10.1002/hep.30233.
    >> Share

  801. MANTOVANI S, Oliviero B, Lombardi A, Varchetta S, et al
    Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma.
    Hepatology. 2018 Aug 28. doi: 10.1002/hep.30235.
    >> Share

  802. MARETTI-MIRA AC, Wang X, Wang L, DeLeve LD, et al
    Incomplete differentiation of engrafted bone marrow endothelial progenitor cells initiates hepatic fibrosis in the rat.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30227.
    >> Share

  803. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    >> Share

  804. LIGAT G, Schuster C, Baumert TF
    HBV core variants, liver fibrosis and hepatocellular carcinoma.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30231.
    >> Share

  805. HLADY RA, Sathyanarayan A, Thompson JJ, Zhou D, et al
    Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 22. doi: 10.1002/hep.30211.
    >> Share

  806. KO S, Monga SP
    Hepatic zonation now on hormones!
    Hepatology. 2018 Aug 18. doi: 10.1002/hep.30221.
    >> Share

  807. INADA Y, Mizukoshi E, Seike T, Tamai T, et al
    Characteristics of immune response to tumor-associated antigens and immune cell profile in hepatocellular carcinoma patients.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30212.
    >> Share

  808. WANG X, Ribeiro M, Iracheta-Vellve A, Lowe P, et al
    Macrophage-specific HIF-1alpha contributes to impaired autophagic flux in non-alcoholic steatohepatitis.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30215.
    >> Share

  809. GHALLAB A, Hofmann U, Sezgin S, Vartak N, et al
    Bile micro-infarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood.
    Hepatology. 2018 Aug 13. doi: 10.1002/hep.30213.
    >> Share

  810. PANDEY S
    Letter to the Editor: The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice: A Public Health Perspective.
    Hepatology. 2018 Aug 4. doi: 10.1002/hep.30207.
    >> Share

  811. YANG L, Wang W, Wang X, Zhao J, et al
    CREG in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.
    Hepatology. 2018 Aug 4. doi: 10.1002/hep.30203.
    >> Share

  812. GORGIS NM, Kennedy C, Lam F, Thompson K, et al
    Clinical Consequences of Cardiomyopathy in Children with Biliary Atresia Requiring Liver Transplantation.
    Hepatology. 2018 Aug 3. doi: 10.1002/hep.30204.
    >> Share

  813. YKI-JARVINEN H
    Diabetes, liver cancer and cirrhosis: What next?
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30136.
    >> Share

  814. ALCARAZ-QUILES J, Casulleras M, Oettl K, Titos E, et al
    Oxidized albumin triggers a cytokine storm in leukocytes through p38 MAP kinase: role in systemic inflammation in decompensated cirrhosis.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30135.
    >> Share

  815. L'HERMITTE A, Pham S, Cadoux M, Couchy G, et al
    Lect2 controls inflammatory monocytes to constrain the growth and progression of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30140.
    >> Share

  816. LI CL, Li CY, Lin YY, Ho MC, et al
    Androgen Receptor Enhances Hepatic TERT Transcription after Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30201.
    >> Share

  817. GANE EJ, Stedman CA, Schwabe C, Vijgen L, et al
    Short Duration AL-335, Odalasvir, With/Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30126.
    >> Share

  818. LIU LZ, Zhang Z, Zheng BH, Shi Y, et al
    CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30134.
    >> Share

  819. FORDE KA, Fallon MB, Krowka MJ, Sprys M, et al
    Pulse Oximetry is Insensitive for Detection of Hepatopulmonary Syndrome in Patients evaluated for Liver Transplantation.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30139.
    >> Share

  820. YOUNOSSI ZM
    Patient-reported Outcomes and the Economic Effects of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis - The Value Proposition.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30125.
    >> Share

  821. COTTON RT, Tran Cao HS, Rana AA, Sada YH, et al
    Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30128.
    >> Share

  822. DROLZ A, Horvatits T, Rutter K, Landahl F, et al
    Lactate improves prediction of short-term mortality in critically ill cirrhosis patients: a multinational study.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30151.
    >> Share

  823. SINGAL AG, Tiro JA, Murphy CC, Marrero JA, et al
    Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients with Cirrhosis: A Randomized Clinical Trial.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30129.
    >> Share

  824. HLADY RA, Robertson KD
    A three-pronged epigenetic approach to the treatment of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30133.
    >> Share

  825. LIU J, Jiang J, Mo J, Liu D, et al
    Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30146.
    >> Share

  826. SHEN Y, Czaja MJ
    A Novel Mechanism of Starvation-Stimulated Hepatic Autophagy: Calcium-Induced O-GlcNAc-Dependent Signaling.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30118.
    >> Share

  827. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    >> Share

  828. LINDOR KD, Bowlus CL, Boyer J, Levy C, et al
    Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30145.
    >> Share

  829. TAFESH ZH, Brown RS Jr, Russo N, Rosenblatt R, et al
    Hepatology Highlights.
    Hepatology. 2018;68:393-396.
    >> Share

  830. DE MATTOS AZ, de Mattos AA
    Evaluating Prognosis of Patients With Acute-On-Chronic Liver Failure: Is the Simplest Score Good Enough?
    Hepatology. 2018;68:790.
    >> Share

  831. O'LEARY JG, Rajender Reddy K, Wong F, Garcia-Tsao G, et al
    Reply.
    Hepatology. 2018;68:791.
    >> Share

  832. PENG TC
    Role of Sarcopenia in Nonalcoholic Fatty Liver Disease: Definition Is Crucially Important.
    Hepatology. 2018;68:788-789.
    >> Share

  833. GRETEN TF
    The ABC of adaptive immunity in liver cancer.
    Hepatology. 2018;68:777-779.
    >> Share

  834. HUANG R, Gao ZH, Tang A, Sebastiani G, et al
    Transient elastography is an unreliable marker of liver fibrosis in patients with portal vein thrombosis.
    Hepatology. 2018;68:783-785.
    >> Share

  835. MOEST W, van der Deure W, Koster T, Spee-Dropkova M, et al
    Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas.
    Hepatology. 2018;68:780-782.
    >> Share

  836. DUAN JL, Ruan B, Yan XC, Liang L, et al
    Endothelial Notch activation reshapes the angiocrine of sinusoidal endothelia to aggravate liver fibrosis and blunt regeneration in mice.
    Hepatology. 2018;68:677-690.
    >> Share

  837. CAUSSY C, Reeder SB, Sirlin CB, Loomba R, et al
    Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
    Hepatology. 2018;68:763-772.
    >> Share

  838. WANGENSTEEN KJ, Wang YJ, Dou Z, Wang AW, et al
    Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
    Hepatology. 2018;68:663-676.
    >> Share

  839. LUDVIGSSON JF, Marschall HU, Hagstrom H, Hoijer J, et al
    Pregnancy outcome in women undergoing liver biopsy during pregnancy: A nationwide population-based cohort study.
    Hepatology. 2018;68:625-633.
    >> Share

    July 2018
  840. HERNANDEZ-GEA V, Baiges A, Turon F, Garcia-Pagan JC, et al
    Idiopathic Portal Hypertension.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30132.
    >> Share

  841. GARCIA-TSAO G, Fuchs M, Shiffman M, Borg BB, et al
    Emricasan (IDN-6556) Lowers Portal Pressure in Patients with Compensated Cirrhosis and Severe Portal Hypertension.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30199.
    >> Share

  842. LOOMES KM, Spino C, Goodrich NP, Hangartner TN, et al
    Bone Density in Children with Chronic Liver Disease Correlates with Growth and Cholestasis.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30196.
    >> Share

  843. CORTES E, Lachowski D, Rice A, Chronopoulos A, et al
    RAR-beta is downregulated in HCC & cirrhosis and its expression inhibits myosin-driven activation and durotaxis in hepatic stellate cells.
    Hepatology. 2018 Jul 28. doi: 10.1002/hep.30193.
    >> Share

  844. MAZZARELLI C, Cannon MD, Hudson M, Heaton N, et al
    Hepatocellular Carcinoma as a complication of vascular disease of the liver after Fontan procedure.
    Hepatology. 2018 Jul 28. doi: 10.1002/hep.30194.
    >> Share

  845. LI W, Li Y, Siraj S, Jin H, et al
    FUNDC1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation.
    Hepatology. 2018 Jul 27. doi: 10.1002/hep.30191.
    >> Share

  846. RODERFELD M, Padem S, Lichtenberger J, Quack T, et al
    Schistosoma mansoni egg secreted antigens activate HCC-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes.
    Hepatology. 2018 Jul 27. doi: 10.1002/hep.30192.
    >> Share

  847. VITALE A, Farinati F, Noaro G, Burra P, et al
    Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study.
    Hepatology. 2018 Jul 26. doi: 10.1002/hep.30185.
    >> Share

  848. DIAZ-GONZALEZ A, Monclus E, Darnell A, Sole M, et al
    Liver metastases from gastric adenocarcinoma mimicking multinodular hepatocellular carcinoma.
    Hepatology. 2018 Jul 25. doi: 10.1002/hep.30120.
    >> Share

  849. ARAB JP, Arrese M
    "Old remedies to heal the liver: novel effects of digoxin in hepatic sterile inflammation".
    Hepatology. 2018 Jul 23. doi: 10.1002/hep.30188.
    >> Share

  850. HONG W, Zhang CZ, Lu SX, Zhang MF, et al
    A CCDC50 splice variant is modulated by SRSF3 and promotes hepatocellular carcinoma via the Ras signaling pathway.
    Hepatology. 2018 Jul 20. doi: 10.1002/hep.30147.
    >> Share

  851. ZHOU X, Wen Y, Tian Y, He M, et al
    Hsp90alpha-dependent Bclaf1 promotes hepatocellular carcinoma proliferation by regulating c-MYC mRNA stability.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30172.
    >> Share

  852. VUPPALANCHI R, Mathur K, Pyko M, Samala N, et al
    Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension - The Devil is In the Details.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30167.
    >> Share

  853. ROMAN E, Gely C, Flavia M, Poca M, et al
    Patients with compensated cirrhosis are also at risk of falling.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30180.
    >> Share

  854. NAVIN P, Hilscher M, Welle C, Mounajjed T, et al
    The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30175.
    >> Share

  855. SAYINER M, Golabi P, Stepanova M, Younossi I, et al
    Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Utilization.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30174.
    >> Share

  856. LIAO SH, Su TH, Jeng YM, Liang PC, et al
    Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30162.
    >> Share

  857. CINGOLANI F, Czaja MJ
    Oxidized Albumin - a Trojan Horse for p38 MAPK-Mediated Inflammation in Decompensated Cirrhosis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30164.
    >> Share

  858. ZHANG J, Han C, Ungerleider N, Chen W, et al
    A novel TGF-beta and H19 signaling axis in tumor-initiating hepatocytes that regulates hepatic carcinogenesis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30153.
    >> Share

  859. BARCENA-VARELA M, Caruso S, Llerena S, Alvarez-Sola G, et al
    Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.
    >> Share

  860. KIM D, Li AA, Perumpail BJ, Gadiparthi C, et al
    Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30161.
    >> Share

  861. HAIDER C, Hnat J, Wagner R, Huber H, et al
    Transforming Growth Factor-beta and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30166.
    >> Share

  862. RUSSO N, Brown RS Jr, Shen NT, Pisa JF, et al
    Hepatology highlights.
    Hepatology. 2018;68:1-3.
    >> Share

  863. POLYZOS SA, Kountouras J, Anastasiadis S, Doulberis M, et al
    Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?
    Hepatology. 2018;68:389.
    >> Share

  864. VERMA N, Singh A, Singh V
    Reply.
    Hepatology. 2018;68:388.
    >> Share

  865. CARR RM
    Proton pump inhibitors, Enterococcus, and the liver, oh my!
    Hepatology. 2018;68:376-379.
    >> Share

  866. ARMENGOL C, Cairo S
    Identification of theranostic biomarkers to improve the stratification of patients with pediatric liver cancer: Opportunities and challenges.
    Hepatology. 2018;68:10-12.
    >> Share

  867. HERNAEZ R, Kanwal F, El-Serag HB
    Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis.
    Hepatology. 2018;68:7-9.
    >> Share

  868. BILL R, Montani M, Blum B, Dufour JF, et al
    Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.
    Hepatology. 2018;68:384-386.
    >> Share

  869. ORLIEN SMS, Sandven I, Berhe NB, Ismael NY, et al
    Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study.
    Hepatology. 2018;68:248-257.
    >> Share

  870. CAI Y, Li H, Liu M, Pei Y, et al
    Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.
    Hepatology. 2018;68:48-61.
    >> Share

    June 2018
  871. HUI ST, Kurt Z, Tuominen I, Norheim F, et al
    The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice.
    Hepatology. 2018 Jun 16. doi: 10.1002/hep.30113.
    >> Share

  872. HAYASHI S, Khan A, Simons BC, Homan C, et al
    A novel association between core mutations in hepatitis B virus genotype F1b and hepatocellular carcinoma in Alaskan Native People.
    Hepatology. 2018 Jun 12. doi: 10.1002/hep.30111.
    >> Share

  873. BHUSHAN B, Stoops JW, Mars WM, Orr A, et al
    TCPOBOP-induced hepatomegaly & hepatocyte proliferation is attenuated by combined disruption of MET & EGFR signaling.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30109.
    >> Share

  874. CHINO F, Pollis KE, Choi S, Salama JK, et al
    Stereotactic Body Radiation Therapy-induced Abscopal Effect on Hepatocellular Carcinoma after Treatment for Lung Cancer: A Case Report.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30100.
    >> Share

  875. PELLICANO R, Durazzo M
    Upper GI bleeding in cirrhotic patients: Which method to search for Helicobacter pylori infection?
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30108.
    >> Share

  876. RUSSO N, Brown RS Jr, Cohen-Mekelburg S, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2018;67:2065-2067.
    >> Share

  877. HUO TI, Hsu CY, Liu PH
    Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma?
    Hepatology. 2018;67:2482-2483.
    >> Share

  878. DEAR JW
    New biomarkers for drug-induced liver injury.
    Hepatology. 2018;67:2480-2481.
    >> Share

  879. ZHANG C, Song F
    Knockout of ULK1/2 protects against acetaminophen-induced acute liver injury independent of autophagy?
    Hepatology. 2018;67:2476-2477.
    >> Share

  880. LAI S, Iwakiri Y
    Is miR-21 a potent target for liver fibrosis?
    Hepatology. 2018;67:2082-2084.
    >> Share

  881. BELLENTANI S, Bedogni G, Tiribelli C
    Two drinks per day does not take your fatty liver away.
    Hepatology. 2018;67:2072-2073.